{"content":"<li class=\"n-box-item date-title\" data-end=\"1509767999\" data-start=\"1509681600\" data-txt=\"Monday, December 23, 2019\">Friday, November  3, 2017</li><li class=\"n-box-item sa-box-item\" data-id=\"3308341\" data-ts=\"1509751463\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/QCOM\" target=\"_blank\">QCOM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3308341-analyst-reactions-broadcom-qualcomm-send-ripples-through-sector\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Analyst reactions: Broadcom-Qualcomm would send ripples through sector</a></h4><ul>   <li>A potential <a href=\"https://seekingalpha.com/news/3308253-qualcomm-rumor-broadcom-interest-update\" target=\"_blank\">$70/share bid</a> for Qualcomm (<a href=\"http://seekingalpha.com/symbol/QCOM\" target=\"_blank\">QCOM</a> <font color='green'>+12.7%</font>) from Broadcom (<a href=\"http://seekingalpha.com/symbol/AVGO\" target=\"_blank\">AVGO</a> <font color='green'>+5.5%</font>) feels a \"little low,\" Nomura says, looking more toward a 50% premium typical to major deals in the sector.</li>    <li>As far as Qualcomm's bid for NXP Semiconductors (<a href=\"http://seekingalpha.com/symbol/NXPI\" target=\"_blank\">NXPI</a> <font color='red'>-2.1%</font>), there's a scenario where Broadcom buys both companies, sets a licensing deal with Apple, then spins off noncore operations that could help fund the deals, Nomura's Romit Shah says.</li>    <li>The deal \"makes sense for a bunch of different reasons,\" including scale, high accretion to EPS and that it's a very strategic deal with both companies' presence in smartphones, Shah <a href=\"https://finance.yahoo.com/video/why-broadcom-qualcomm-deal-makes-201800287.html\" target=\"_blank\">tells Bloomberg Television</a>.</li>    <li>Cavium (<a href=\"http://seekingalpha.com/symbol/CAVM\" target=\"_blank\">CAVM</a> <font color='green'>+3.4%</font>) and AMD (<a href=\"http://seekingalpha.com/symbol/AMD\" target=\"_blank\">AMD</a> <font color='green'>+2.5%</font>) could benefit from such a merger, BofA Merrill Lynch says, while the implications are more mixed for Intel (<a href=\"http://seekingalpha.com/symbol/INTC\" target=\"_blank\">INTC</a> <font color='red'>-1.6%</font>), Skyworks (<a href=\"http://seekingalpha.com/symbol/SWKS\" target=\"_blank\">SWKS</a> <font color='green'>+1.3%</font>), Qorvo (<a href=\"http://seekingalpha.com/symbol/QRVO\" target=\"_blank\">QRVO</a> <font color='red'>-0.6%</font>) and Xilinx (<a href=\"http://seekingalpha.com/symbol/XLNX\" target=\"_blank\">XLNX</a> <font color='green'>+0.4%</font>). Intel could face more competition in mobile processing but the pricing environment could improve.</li>    <li>At SunTrust, analyst William Stein and team say Broadcom's \"<a href=\"http://www.barrons.com/articles/the-hot-stock-broadcom-shows-qualcomm-the-love-1509748489\" target=\"_blank\">tactic is sensible, strategy somewhat less clear</a> to us.\"</li>    <li>The deal fits with Broadcom's longstanding approach to take over leading franchises, they write, but: \"Since we began covering AVGO, one major investor concern has been the company's exposure to the volatile handset market (~30% of sales). As QCOM has ~90% of sales from the handset market, it would take the combined company's exposure to ~65% of sales, potentially challenging our view that AVGO deserves an expanded P/E.\"</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3308341\" data-linked=\"Analyst reactions: Broadcom-Qualcomm would send ripples through sector\" data-tweet=\"$QCOM $QCOM $AVGO - Analyst reactions: Broadcom-Qualcomm would send ripples through sector https://seekingalpha.com/news/3308341-analyst-reactions-broadcom-qualcomm-send-ripples-through-sector?source=tweet\" data-url=\"https://seekingalpha.com/news/3308341-analyst-reactions-broadcom-qualcomm-send-ripples-through-sector\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:24 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>155&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3308340\" data-ts=\"1509751079\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MRVL\" target=\"_blank\">MRVL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3308340-chip-deal-heat-caviumplus-9_1-on-advanced-merger-talks-marvell\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Chip deal heat: Cavium +9.1% on advanced merger talks with Marvell</a></h4><ul>   <li>Cavium (<a href=\"http://seekingalpha.com/symbol/CAVM\" target=\"_blank\">CAVM</a> <font color='green'>+3.4%</font>) is <font color='green'>up 9.1%</font> after hours after a Wall Street Journal report notes Marvell Technology (<a href=\"http://seekingalpha.com/symbol/MRVL\" target=\"_blank\">MRVL</a> <font color='green'>+1.3%</font>) is in <a href=\"https://www.wsj.com/articles/marvell-technology-group-in-advanced-talks-to-combine-with-cavium-1509744822\" target=\"_blank\">advanced merger talks</a> with the company to create a $14B chipmaker.</li>    <li>Marvell, with a $9B market value, is <font color='green'>up 4.8%</font> on the news.</li>    <li>As currently envisioned, Cavium would get a modest premium, according to the report.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3308340\" data-linked=\"Chip deal heat: Cavium +9.1% on advanced merger talks with Marvell\" data-tweet=\"$MRVL - Chip deal heat: Cavium +9.1% on advanced merger talks with Marvell https://seekingalpha.com/news/3308340-chip-deal-heat-caviumplus-9_1-on-advanced-merger-talks-marvell?source=tweet\" data-url=\"https://seekingalpha.com/news/3308340-chip-deal-heat-caviumplus-9_1-on-advanced-merger-talks-marvell\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:17 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3308338\" data-ts=\"1509749360\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NEOS\" target=\"_blank\">NEOS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3308338-takeout-rumors-flying-neos-therapeutics-wraps-week-bang\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">With takeout rumors flying, Neos Therapeutics wraps week with a bang</a></h4><ul>   <li>Neos Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/NEOS' title='Neos Therapeutics'>NEOS</a>) vaulted into today's close -- with volume spiking in the last seven minutes to finish the day <font color='green'>up 27.1%</font> -- amid chatter that it's <a href=\"https://seekingalpha.com/news/3306227-neos-consider-offers-rejecting-pdl-bid-10_25\" target=\"_blank\">looking at other bids</a> after rejecting an unsolicited offer from PDL BioPharma (<a href=\"http://seekingalpha.com/symbol/PDLI\" target=\"_blank\">PDLI</a> <font color='green'>+4.1%</font>).</li>    <li>That raises the prospect of a bidding war, and loose rumors of an announcement over the weekend.</li>    <li>After that sudden gain in regular trading, Neos shares are <font color='red'>off 8.1%</font> after hours, quoting at $11.85.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3308338\" data-linked=\"With takeout rumors flying, Neos Therapeutics wraps week with a bang\" data-tweet=\"$NEOS $NEOS $PDLI - With takeout rumors flying, Neos Therapeutics wraps week with a bang https://seekingalpha.com/news/3308338-takeout-rumors-flying-neos-therapeutics-wraps-week-bang?source=tweet\" data-url=\"https://seekingalpha.com/news/3308338-takeout-rumors-flying-neos-therapeutics-wraps-week-bang\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:49 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3308333\" data-ts=\"1509745351\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3308333-after-hours-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After Hours Gainers / Losers</a></h4><ul>     <li><b>Top gainers, as of 5.25 p.m.:</b> <a href='https://seekingalpha.com/symbol/TWIN' title='Twin Disc, Incorporated'>TWIN</a> <font color='green'>+6.1%</font>. <a href='https://seekingalpha.com/symbol/EBS' title='Emergent BioSolutions Inc.'>EBS</a> <font color='green'>+3.7%</font>. <a href='https://seekingalpha.com/symbol/GTT' title='GTT Communications, Inc.'>GTT</a> <font color='green'>+3.0%</font>. <a href='https://seekingalpha.com/symbol/IMMU' title='Immunomedics, Inc.'>IMMU</a> <font color='green'>+2.1%</font>. CAVM <font color='green'>+2.0%</font>.</li><li><b>Top losers, as of 5.25p.m.:</b> <a href='https://seekingalpha.com/symbol/NEOS' title='Neos Therapeutics'>NEOS</a> <font color='red'>-7.3%</font>. <a href='https://seekingalpha.com/symbol/DCIX' title='Diana Containerships Inc.'>DCIX</a> <font color='red'>-6.3%</font>. <a href='https://seekingalpha.com/symbol/GGB' title='Gerdau S.A.'>GGB</a> <font color='red'>-2.7%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3308333\" data-linked=\"After Hours Gainers / Losers\" data-tweet=\"$TWIN $EBS $GTT - After Hours Gainers / Losers https://seekingalpha.com/news/3308333-after-hours-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3308333-after-hours-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:42 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3308332\" data-ts=\"1509744394\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PZZA\" target=\"_blank\">PZZA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3308332-papa-johns-rethinking-nfl-sponsorship\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Papa John&#39;s: We&#39;re rethinking NFL sponsorship</a></h4><ul>     <li>Pizza maker Papa John's (<a href=\"http://seekingalpha.com/symbol/PZZA\" target=\"_blank\">PZZA</a> <font color='red'>-2.5%</font>) is keeping up the heat on the NFL in its national anthem-related attacks this week, saying today it's <a href=\"https://www.wsj.com/articles/papa-johns-says-its-evaluating-nfl-sponsorship-1509741470\" target=\"_blank\">re-evaluating its sponsorship of the league</a>.</li>     <li>During the chain's earnings call Wednesday, CEO John Schnatter blamed slowing sales on NFL leadership's handling of player protests during the playing of the national anthem. Pizza stocks declined, then recovered yesterday with some analysts calling the worries overblown.</li>     <li>In an interview, Papa John's chief marketing officer says consumers' shift to digital is making them re-think how they advertise. &ldquo;We have to evaluate our reliance on partnerships that are TV-focused, like the NFL,&rdquo; says CMO Brandon Rhoten.</li>     <li>&ldquo;If the viewership decline continues, we will need to shift into things that work more effectively for us,&rdquo; says Chief Operating Officer Steve Ritchie.</li>     <li>Papa John's has been a major partner with the league since 2010, and is the official sponsor of the Super Bowl.</li>     <li>Ratings have fallen about 5% Y/Y this year, and are down about 15% vs. the same period in 2015.</li>     <li>Previously: <a href=\"https://seekingalpha.com/news/3307595-pizza-rally-nfl-worries-fade\" target=\"_blank\">Pizza rally as NFL worries fade</a> (Nov. 02 2017)</li>     <li>Previously: <a href=\"https://seekingalpha.com/news/3307479-analysts-reset-papa-johns\" target=\"_blank\">Analysts reset on Papa John's</a> (Nov. 02 2017)</li>     <li>Previously: <a href=\"https://seekingalpha.com/news/3306696-papa-johns-links-nfl-anthem-protests-soft-sales\" target=\"_blank\">Papa John's links NFL anthem protests to soft sales</a> (Nov. 01 2017)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3308332\" data-linked=\"Papa John&#39;s: We&#39;re rethinking NFL sponsorship\" data-tweet=\"$PZZA - Papa John&#39;s: We&#39;re rethinking NFL sponsorship https://seekingalpha.com/news/3308332-papa-johns-rethinking-nfl-sponsorship?source=tweet\" data-url=\"https://seekingalpha.com/news/3308332-papa-johns-rethinking-nfl-sponsorship\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:26 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>41&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3308319\" data-ts=\"1509742800\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3308319-weekly-etf-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Weekly ETF Gainers / Losers</a></h4><ul>     <li><b>Top gainers:</b> <a href='https://seekingalpha.com/symbol/FCG' title='First Trust Natural Gas ETF'>FCG</a> <font color='green'>+4.1%</font>. <a href='https://seekingalpha.com/symbol/OIL' title='iPath S&P Crude Oil Total Return Index ETN'>OIL</a> <font color='green'>+4.1%</font>. <a href='https://seekingalpha.com/symbol/BNO' title='The United States Brent Oil ETF, LP'>BNO</a> <font color='green'>+3.5%</font>. <a href='https://seekingalpha.com/symbol/USO' title='The United States Oil ETF, LP'>USO</a> <font color='green'>+3.1%</font>. <a href='https://seekingalpha.com/symbol/EWY' title='iShares MSCI South Korea Capped ETF'>EWY</a> <font color='green'>+3.1%</font>.</li><li><b>Top losers:</b> <a href='https://seekingalpha.com/symbol/EWZ' title='iShares MSCI Brazil Capped ETF'>EWZ</a> <font color='red'>-5.4%</font>. <a href='https://seekingalpha.com/symbol/BRF' title='VanEck Vectors Brazil Small-Cap ETF'>BRF</a> <font color='red'>-5.0%</font>. <a href='https://seekingalpha.com/symbol/GAZ' title='iPath DJ-UBS Natural Gas Total Return Sub-Index ETN'>GAZ</a> <font color='red'>-3.9%</font>. <a href='https://seekingalpha.com/symbol/ILF' title='iShares Latin America 40 ETF'>ILF</a> <font color='red'>-3.5%</font>. <a href='https://seekingalpha.com/symbol/KBWD' title='PowerShares KBW High Dividend Yield Financial Portfolio ETF'>KBWD</a> <font color='red'>-2.5%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3308319\" data-linked=\"Weekly ETF Gainers / Losers\" data-tweet=\"$FCG $OIL $BNO - Weekly ETF Gainers / Losers https://seekingalpha.com/news/3308319-weekly-etf-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3308319-weekly-etf-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3308315\" data-ts=\"1509741169\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KERX\" target=\"_blank\">KERX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3308315-fda-action-date-monday-on-keryx-bios-auryxia-for-anemia-in-ckd-patients\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FDA action date Monday on Keryx Bio&#39;s Auryxia for anemia in CKD patients</a></h4><ul><li>Monday is the FDA's action date &#40;PDUFA&#41; for its review of Keryx Biopharmaceuticals' (NASDAQ:<a href='https://seekingalpha.com/symbol/KERX' title='Keryx Biopharmaceuticals, Inc.'>KERX</a>) marketing application seeking approval to use AURYXIA (ferric citrate) to treat iron deficiency anemia in patients with non-dialysis-dependent chronic kidney disease &#40;CKD&#41;.</li><li><a href=\"https://www.auryxia.com/\" target=\"_blank\">AURYXIA&nbsp;</a>is currently approved in the U.S. for the control of serum phosphorus levels in CKD patients on dialysis.</li><li>Shares were up almost&nbsp;<font color='green'>11%</font>&nbsp;today on more than double normal volume.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3299812-keryx-perks-ahead-fda-decision-expanded-use-auryxia-shares-ahead-7-percent\" target=\"_blank\">Keryx perks up ahead of FDA decision on expanded use of Auryxia; shares ahead 7%</a> (Oct. 6)</li></ul><div class=\"tiny-share-widget\" data-id=\"3308315\" data-linked=\"FDA action date Monday on Keryx Bio&#39;s Auryxia for anemia in CKD patients\" data-tweet=\"$KERX - FDA action date Monday on Keryx Bio&#39;s Auryxia for anemia in CKD patients https://seekingalpha.com/news/3308315-fda-action-date-monday-on-keryx-bios-auryxia-for-anemia-in-ckd-patients?source=tweet\" data-url=\"https://seekingalpha.com/news/3308315-fda-action-date-monday-on-keryx-bios-auryxia-for-anemia-in-ckd-patients\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:32 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>37&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3308311\" data-ts=\"1509740953\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CRCM\" target=\"_blank\">CRCM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3308311-care-com-closes-up-15-after-q3-beats-in-line-to-upside-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Care.com closes up 15% after Q3 beats, in-line to upside guidance</a></h4><ul><li>        Care.com (NYSE:<a href='https://seekingalpha.com/symbol/CRCM' title='Care.com, Inc.'>CRCM</a>) closed today&nbsp;<font color='green'>up 15.13%</font>&nbsp;after yesterday&rsquo;s Q3 report beat revenue and EPS estimates with in-line and above guidance.</li><li>               Q4 guidance: revenue, $43.6M to $44.1M (consensus: $44.02M); EPS, $0.15 to $0.16 (consensus: $0.17).&nbsp;</li><li>               FY17 guidance: revenue, $173.5M to $174M (consensus: $173.44M); EPS, $0.51 to $0.52 (consensus: $0.44).&nbsp;</li><li>               Initial FY18 guidance: revenue, $190M (consensus: $190.29M); EPS, $0.65 (consensus: $0.51).&nbsp;</li><li>               <a href=\"http://www.nasdaq.com/press-release/carecom-announces-third-quarter-2017-financial-results-and-raises-fullyear-2017-guidance-20171102-00254\" target=\"_blank\">Press release</a>&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3307173-care-com-beats-0_11-beats-revenue\" target=\"_blank\">Care.com beats by $0.11, beats on revenue</a> (Nov. 2)</li></ul><div class=\"tiny-share-widget\" data-id=\"3308311\" data-linked=\"Care.com closes up 15% after Q3 beats, in-line to upside guidance\" data-tweet=\"$CRCM - Care.com closes up 15% after Q3 beats, in-line to upside guidance https://seekingalpha.com/news/3308311-care-com-closes-up-15-after-q3-beats-in-line-to-upside-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3308311-care-com-closes-up-15-after-q3-beats-in-line-to-upside-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:29 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3308304\" data-ts=\"1509740470\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TXMD\" target=\"_blank\">TXMD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3308304-therapeuticsmd-to-release-q3-results-and-update-investors-on-txminus-004hr-on-monday\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">TherapeuticsMD to release Q3 results and update investors on TX-004HR on Monday</a></h4><ul><li>TherapeuticsMD (NYSEMKT:<a href='https://seekingalpha.com/symbol/TXMD' title='TherapeuticsMD'>TXMD</a>) will host a conference call on Monday, November 6, at 8:00 am ET to discuss Q3 results and update investors on the regulatory status of TX-004HR after today's meeting with the FDA.</li><li>The company received a CRL in August citing the need for long-term safety data beyond the 12 weeks in the REJOICE study.</li><li>The proposed indication for TX-004HR (estradiol vaginal softgel capsule) is the treatment of women with moderate-to-severe vaginal pain during intercourse (dyspareunia).</li><li>Shares were down almost&nbsp;<font color='red'>6%</font>&nbsp;today in nearly double normal volume.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3288437-fda-wants-long-term-safety-data-therapeuticsmds-txminus-004hr-meeting-set-november-3\" target=\"_blank\">FDA wants long-term safety data on TherapeuticsMD's TX-004HR, meeting set for November 3 to determine if data sufficient to resolve CRL; shares down 7% after hours</a> (Aug. 10)</li></ul><div class=\"tiny-share-widget\" data-id=\"3308304\" data-linked=\"TherapeuticsMD to release Q3 results and update investors on TX-004HR on Monday\" data-tweet=\"$TXMD - TherapeuticsMD to release Q3 results and update investors on TX-004HR on Monday https://seekingalpha.com/news/3308304-therapeuticsmd-to-release-q3-results-and-update-investors-on-txminus-004hr-on-monday?source=tweet\" data-url=\"https://seekingalpha.com/news/3308304-therapeuticsmd-to-release-q3-results-and-update-investors-on-txminus-004hr-on-monday\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:21 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>19&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3308295\" data-ts=\"1509738870\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NTIP\" target=\"_blank\">NTIP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3308295-networkminus-1-technologies-settles-patent-dispute-juniper-networks\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Network-1 Technologies settles patent dispute with Juniper Networks</a></h4><ul><li>        Network-1 Technologies (NYSEMKT:<a href='https://seekingalpha.com/symbol/NTIP' title='Network-1 Technologies, Inc.'>NTIP</a>) <a href=\"https://seekingalpha.com/pr/16990619-networkminus-1-announces-settlement-patent-litigation-juniper-networks-inc\" target=\"_blank\">announces</a> the settlement of its patent litigation against Juniper Networks (NYSE:<a href='https://seekingalpha.com/symbol/JNPR' title='Juniper Networks'>JNPR</a>).</li><li>               Juniper will pay $13.25M and receive a full license for Network-1&rsquo;s Remote Power Patent at the heart of the case.&nbsp;</li><li>               The license expires in March 2020.&nbsp;</li><li>               Network-1 shares are&nbsp;<font color='green'>up 2.41%</font>.&nbsp;</li><li>               Juniper shares are&nbsp;<font color='green'>up 0.68%</font>. &nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3308295\" data-linked=\"Network-1 Technologies settles patent dispute with Juniper Networks\" data-tweet=\"$NTIP $NTIP $JNPR - Network-1 Technologies settles patent dispute with Juniper Networks https://seekingalpha.com/news/3308295-networkminus-1-technologies-settles-patent-dispute-juniper-networks?source=tweet\" data-url=\"https://seekingalpha.com/news/3308295-networkminus-1-technologies-settles-patent-dispute-juniper-networks\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:54 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3308291\" data-ts=\"1509738294\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BNFT\" target=\"_blank\">BNFT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3308291-benefitfocus-down-after-q3-beats-due-to-mixed-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Benefitfocus down after Q3 beats due to mixed guidance</a></h4><ul><li>        Benefitfocus (NASDAQ:<a href='https://seekingalpha.com/symbol/BNFT' title='Benefitfocus, Inc.'>BNFT</a>) shares are&nbsp;<font color='red'>down 3.35%</font>&nbsp;after yesterday&rsquo;s Q3 report beat EPS and revenue estimates but had mixed guidance.</li><li>               Q4 guidance: revenue, $66M to $67M (consensus: $66.8M); EPS, -$0.08 to -$0.05 (consensus: -$0.01).&nbsp;</li><li>               Full-year 2017 guidance: revenue, $256M to $257M (consensus: $256.47M); EPS, -$0.29 to -$0.26 (consensus: -$0.30).&nbsp;</li><li>               <a href=\"https://seekingalpha.com/pr/16990048-benefitfocus-announces-third-quarter-2017-financial-results\" target=\"_blank\">Press release</a>&nbsp;</li><li>               Analyst action:&nbsp;William Blair <a href=\"https://mail.google.com/mail/u/0/?ui=2&amp;view=btop&amp;ver=pci96guoc0cg&amp;q=BNFT&amp;qs=true&amp;search=query&amp;th=15f816a2357879bc&amp;qt=bnft.1&amp;cvid=1\" target=\"_blank\">downgrades</a> Benefitfocus from Outperform to Market Perform following the earnings report.&nbsp;&nbsp;&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3307759-benefitfocus-beats-0_08-beats-revenue\" target=\"_blank\">Benefitfocus beats by $0.08, beats on revenue</a> (Nov. 2)</li></ul><div class=\"tiny-share-widget\" data-id=\"3308291\" data-linked=\"Benefitfocus down after Q3 beats due to mixed guidance\" data-tweet=\"$BNFT - Benefitfocus down after Q3 beats due to mixed guidance https://seekingalpha.com/news/3308291-benefitfocus-down-after-q3-beats-due-to-mixed-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3308291-benefitfocus-down-after-q3-beats-due-to-mixed-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:44 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3308287\" data-ts=\"1509737324\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AET\" target=\"_blank\">AET</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3308287-cvs-aetna-hope-to-seal-deal-soon-december-reuters\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CVS/Aetna hope to seal deal as soon as December - Reuters</a></h4><ul><li>The two are working on finalizing terms, <a href=\"https://www.reuters.com/article/us-aetna-m-a-cvs-health/cvs-aetna-aim-to-finalize-deal-as-early-as-december-sources-idUSKBN1D32A6\" target=\"_blank\">according to the story</a>, and they've agreed that it'll be a cash and stock deal that could value Aetna (NYSE:<a href='https://seekingalpha.com/symbol/AET' title='Aetna, Inc.'>AET</a>) at significantly more than $200 per share.</li><li>Aetna has&nbsp;<font color='green'>jumped nearly 4%</font>&nbsp;in the past few minutes to $178,72. <a href='https://seekingalpha.com/symbol/CVS' title='CVS Health Corporation'>CVS</a><font color='red'> -0.3%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3308287\" data-linked=\"CVS/Aetna hope to seal deal as soon as December - Reuters\" data-tweet=\"$AET $AET $CVS - CVS/Aetna hope to seal deal as soon as December - Reuters https://seekingalpha.com/news/3308287-cvs-aetna-hope-to-seal-deal-soon-december-reuters?source=tweet\" data-url=\"https://seekingalpha.com/news/3308287-cvs-aetna-hope-to-seal-deal-soon-december-reuters\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:28 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>38&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3308286\" data-ts=\"1509737262\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/COHU\" target=\"_blank\">COHU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3308286-cohu-drops-5_7-despite-q3-beats-upside-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cohu drops 5.7% despite Q3 beats, upside guidance</a></h4><ul><li>        Cohu (NASDAQ:<a href='https://seekingalpha.com/symbol/COHU' title='Cohu, Inc.'>COHU</a>) shares are&nbsp;<font color='red'>down 5.68%</font>&nbsp;despite yesterday&rsquo;s Q3 report beating EPS and revenue estimates. The upside Q4 guidance puts revenue at $84M versus the $83.58M consensus.</li><li>        The earnings release was joined by a regulatory filing showing that director James Donahue sold over 36K shares. &nbsp;</li><li>        <a href=\"https://seekingalpha.com/pr/16989876-cohu-reports-third-quarter-2017-results\" target=\"_blank\">Press release</a> / <a href=\"https://cohu.gcs-web.com/static-files/f0ba9b82-9ac2-4816-9daa-40a53f914f29\" target=\"_blank\">Regulatory filing</a></li><li>Previously: <a href=\"https://seekingalpha.com/news/3307800-cohu-beats-0_04-beats-revenue\" target=\"_blank\">Cohu beats by $0.04, beats on revenue</a> (Nov. 2)</li></ul><div class=\"tiny-share-widget\" data-id=\"3308286\" data-linked=\"Cohu drops 5.7% despite Q3 beats, upside guidance\" data-tweet=\"$COHU - Cohu drops 5.7% despite Q3 beats, upside guidance https://seekingalpha.com/news/3308286-cohu-drops-5_7-despite-q3-beats-upside-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3308286-cohu-drops-5_7-despite-q3-beats-upside-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:27 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3308281\" data-ts=\"1509736003\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VRAY\" target=\"_blank\">VRAY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3308281-viewray-up-15-after-new-orders\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Viewray up 15% after new orders</a></h4><ul><li>The company's&nbsp;MRIdian&reg; Linac <a href=\"https://seekingalpha.com/pr/16990587-viewrays-mridian-linac-selected-mr-guided-radiotherapy-system-danish-tender\" target=\"_blank\">has been selected</a> for&nbsp;installation at Rigshospitalet and Herlev Hospitals in Denmark.</li><li>In other news. holder Fosun International <a href=\"https://seekingalpha.com/filing/3750576\" target=\"_blank\">disclosed a</a> 9.91% stake.</li><li><a href='https://seekingalpha.com/symbol/VRAY' title='ViewRay'>VRAY</a>&nbsp;<font color='green'>+14.7%</font></li></ul><div class=\"tiny-share-widget\" data-id=\"3308281\" data-linked=\"Viewray up 15% after new orders\" data-tweet=\"$VRAY - Viewray up 15% after new orders https://seekingalpha.com/news/3308281-viewray-up-15-after-new-orders?source=tweet\" data-url=\"https://seekingalpha.com/news/3308281-viewray-up-15-after-new-orders\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:06 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3308279\" data-ts=\"1509735667\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RLGY\" target=\"_blank\">RLGY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3308279-realogy-down-10-after-earnings-miss\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Realogy down 10% after earnings miss</a></h4><ul><li>Yesterday's decline came following the release of the GOP tax plan which capped the famed mortgage interest deduction.</li><li>Today, it's Q4 adjusted EPS of $0.71 per share, down from $0.75 a year ago, and shy of estimates by $0.09.</li><li>Transaction volume actually rose 4% Y/Y, and revenue was up 2%. At issue were higher commission splits due to the relative strength on the West Coast, the hurricanes, and weaker Cartus (relocation services) results.</li><li>Free cash flow for the quarter of $249M slipped from $262M a year ago.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3308069-realogy-holdings-misses-0_10-misses-revenue\" target=\"_blank\">Realogy Holdings misses by $0.10, misses on revenue</a> (Nov. 3)</li><li><a href='https://seekingalpha.com/symbol/RLGY' title='Realogy Holdings'>RLGY</a>&nbsp;<font color='red'>-10.4%</font></li></ul><div class=\"tiny-share-widget\" data-id=\"3308279\" data-linked=\"Realogy down 10% after earnings miss\" data-tweet=\"$RLGY - Realogy down 10% after earnings miss https://seekingalpha.com/news/3308279-realogy-down-10-after-earnings-miss?source=tweet\" data-url=\"https://seekingalpha.com/news/3308279-realogy-down-10-after-earnings-miss\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:01 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3308277\" data-ts=\"1509735378\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3308277-technology-top-gainers-losers-of-2-55-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Technology - Top Gainers / Losers as of 2:55 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/VRNS' title='Varonis Systems Inc'>VRNS</a> <font color='green'>+15%</font>. <a href='https://seekingalpha.com/symbol/QBAK' title='Qualstar Corporation'>QBAK</a> <font color='green'>+15%</font>. <a href='https://seekingalpha.com/symbol/WIFI' title='Boingo Wireless'>WIFI</a> <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/CRCM' title='Care.com, Inc.'>CRCM</a> <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/QCOM' title='Qualcomm Inc.'>QCOM</a> <font color='green'>+12%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/RUBI' title='The Rubicon Project, Inc.'>RUBI</a> <font color='red'>-40%</font>. <a href='https://seekingalpha.com/symbol/KEYW' title='KEYW Holding'>KEYW</a> <font color='red'>-34%</font>. <a href='https://seekingalpha.com/symbol/STMP' title='Stamps.com Inc.'>STMP</a> <font color='red'>-21%</font>. <a href='https://seekingalpha.com/symbol/PLUS' title='ePlus Inc.'>PLUS</a> <font color='red'>-20%</font>. <a href='https://seekingalpha.com/symbol/XPER' title='Xperi Corporation'>XPER</a> <font color='red'>-20%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3308277\" data-linked=\"Technology - Top Gainers / Losers as of 2:55 pm\" data-tweet=\"$VRNS $QBAK $WIFI - Technology - Top Gainers / Losers as of 2:55 pm https://seekingalpha.com/news/3308277-technology-top-gainers-losers-of-2-55-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3308277-technology-top-gainers-losers-of-2-55-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:56 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3308267\" data-ts=\"1509734237\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AOSL\" target=\"_blank\">AOSL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3308267-alpha-and-omega-semi-drops-6-after-mixed-q1-lowered-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Alpha and Omega Semi drops 6% after mixed Q1, lowered guidance</a></h4><ul><li>        Alpha and Omega Semi (NASDAQ:<a href='https://seekingalpha.com/symbol/AOSL' title='Alpha and Omega Semiconductor Limited'>AOSL</a>) shares are&nbsp;<font color='red'>down 5.96%</font>&nbsp;after yesterday&rsquo;s Q1 report misses EPS, beats revenue, and lowered guidance.</li><li>               Q2 guidance has revenue at $100M to $104M (consensus: $100.05M; was $101M to $105M) with GAAP gross margin within 1% of 26%.&nbsp;</li><li>               <a href=\"https://seekingalpha.com/pr/16990052-alpha-omega-semiconductor-reports-financial-results-fiscal-first-quarter-2018-ended-september\" target=\"_blank\">Press release</a>&nbsp; &nbsp;&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3307821-alpha-omega-semiconductor-misses-0_01-beats-revenue\" target=\"_blank\">Alpha and Omega Semiconductor misses by $0.01, beats on revenue</a> (Nov. 2)</li></ul><div class=\"tiny-share-widget\" data-id=\"3308267\" data-linked=\"Alpha and Omega Semi drops 6% after mixed Q1, lowered guidance\" data-tweet=\"$AOSL - Alpha and Omega Semi drops 6% after mixed Q1, lowered guidance https://seekingalpha.com/news/3308267-alpha-and-omega-semi-drops-6-after-mixed-q1-lowered-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3308267-alpha-and-omega-semi-drops-6-after-mixed-q1-lowered-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:37 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3308265\" data-ts=\"1509733985\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/YOGA\" target=\"_blank\">YOGA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3308265-imperial-capital-sees-massive-upside-for-yogaworks\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Imperial Capital sees massive upside for YogaWorks</a></h4><ul> <li>Imperial Capital starts off coverage on YogaWorks (<a href='https://seekingalpha.com/symbol/YOGA' title='YogaWorks'>YOGA</a> <font color='green'>+5.1%</font>) with an Outperform rating on its view the company can build a cash flow positive business.</li> <li>The investment firm assigns a price target of <a href=\"http://247wallst.com/investing/2017/11/03/top-analyst-upgrades-and-downgrades-activision-aetna-apple-blue-apron-pandora-starbucks-twitter-yogaworks-and-more/\" target=\"_blank\">$5</a> on the yoga studio operator to rep 79% upside potential.</li><li>YogaWorks priced its IPO at $5.50 last August. Imperial Capital was an <a href=\"http://www.nasdaq.com/markets/ipos/company/yogaworks-inc-1026583-84028?tab=experts\" target=\"_blank\">underwriter</a>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3308265\" data-linked=\"Imperial Capital sees massive upside for YogaWorks\" data-tweet=\"$YOGA - Imperial Capital sees massive upside for YogaWorks https://seekingalpha.com/news/3308265-imperial-capital-sees-massive-upside-for-yogaworks?source=tweet\" data-url=\"https://seekingalpha.com/news/3308265-imperial-capital-sees-massive-upside-for-yogaworks\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:33 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3308264\" data-ts=\"1509733553\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ECOM\" target=\"_blank\">ECOM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3308264-channeladvisor-plunges-18_7-after-downside-q4-lowered-fy-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ChannelAdvisor plunges 18.7% after downside Q4, lowered FY guidance</a></h4><ul><li>        ChannelAdvisor (NYSE:<a href='https://seekingalpha.com/symbol/ECOM' title='ChannelAdvisor Corp'>ECOM</a>) shares are&nbsp;<font color='red'>down 18.7%</font>&nbsp;after yesterday&rsquo;s Q3 report met revenue guidance, missed on EPS, and featured downside Q4 and lowered FY17 guidance.</li><li>               Q4 guidance has revenue at $34M to $34.6M (consensus: $35.58M) and FY17 has $122.4M to $123M (consensus: $123.98M; down from $123M to $124.5M).&nbsp;</li><li>               <a href=\"https://seekingalpha.com/pr/16990117-channeladvisor-announces-third-quarter-2017-financial-results\" target=\"_blank\">Press release</a>&nbsp; &nbsp;&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3307745-channeladvisor-eps-0_15\" target=\"_blank\">ChannelAdvisor EPS of -$0.15</a> (Nov. 2)</li></ul><div class=\"tiny-share-widget\" data-id=\"3308264\" data-linked=\"ChannelAdvisor plunges 18.7% after downside Q4, lowered FY guidance\" data-tweet=\"$ECOM - ChannelAdvisor plunges 18.7% after downside Q4, lowered FY guidance https://seekingalpha.com/news/3308264-channeladvisor-plunges-18_7-after-downside-q4-lowered-fy-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3308264-channeladvisor-plunges-18_7-after-downside-q4-lowered-fy-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:25 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3308259\" data-ts=\"1509732181\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3308259-energy-materials-top-gainers-losers-of-2-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Energy/Materials - Top Gainers / Losers as of 2:00 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/IO' title='ION Geophysical Corporation'>IO</a> <font color='green'>+15%</font>. <a href='https://seekingalpha.com/symbol/TUSK' title='Mammoth Energy Services'>TUSK</a> <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/CRK' title='Comstock Resources Inc.'>CRK</a> <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/RYAM' title='Rayonier Advanced Materials'>RYAM</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/SN' title='Sanchez Energy Corporation'>SN</a> <font color='green'>+9%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/TGA' title='Transglobe Energy Corp'>TGA</a> <font color='red'>-17%</font>. <a href='https://seekingalpha.com/symbol/CC' title='The Chemours Company'>CC</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/AMRS' title='Amyris, Inc.'>AMRS</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/AVD' title='American Vanguard Corporation'>AVD</a> <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/GSM' title='Ferroglobe PLC'>GSM</a> <font color='red'>-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3308259\" data-linked=\"Energy/Materials - Top Gainers / Losers as of 2:00 pm\" data-tweet=\"$IO $TUSK $CRK - Energy/Materials - Top Gainers / Losers as of 2:00 pm https://seekingalpha.com/news/3308259-energy-materials-top-gainers-losers-of-2-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3308259-energy-materials-top-gainers-losers-of-2-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:03 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3308255\" data-ts=\"1509731712\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HCA\" target=\"_blank\">HCA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3308255-rough-day-for-hospital-names-evercore-mulls-medicare-reimbursement-cuts\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Rough day for hospital names; Evercore mulls Medicare reimbursement cuts</a></h4><ul><li>At issue are hospital-level adjustments under Medicare's Value-Based Purchasing Program.</li><li>Evercore's Michael Newshel sees about $15M less reimbursement for HCA (<a href='https://seekingalpha.com/symbol/HCA' title='HCA Holdings, Inc.'>HCA</a> <font color='green'>+0.1%</font>), and a slightly larger cut for Tenet (<a href='https://seekingalpha.com/symbol/THC' title='Tenet Healthcare Corporation'>THC</a> <font color='red'>-4.6%</font>).</li><li>LifePoint (<a href='https://seekingalpha.com/symbol/LPNT' title='LifePoint Health, Inc.'>LPNT</a> <font color='red'>-0.5%</font>), Universal Health (<a href='https://seekingalpha.com/symbol/UHS' title='Universal Health Services Inc.'>UHS</a> <font color='red'>-0.6%</font>), and Quorum Health (<a href='https://seekingalpha.com/symbol/QHC' title='Quorum Health Corporation'>QHC</a> <font color='red'>-13.3%</font>) should see modest improvements, while the Community Health (<a href='https://seekingalpha.com/symbol/CHY' title='Calamos Convertible&High Income Fund'>CHY</a> <font color='red'>-0.2%</font>) adjustment is flat.</li><li>Source: Bloomberg's Tatiana Darie</li></ul><div class=\"tiny-share-widget\" data-id=\"3308255\" data-linked=\"Rough day for hospital names; Evercore mulls Medicare reimbursement cuts\" data-tweet=\"$HCA $HCA $THC - Rough day for hospital names; Evercore mulls Medicare reimbursement cuts https://seekingalpha.com/news/3308255-rough-day-for-hospital-names-evercore-mulls-medicare-reimbursement-cuts?source=tweet\" data-url=\"https://seekingalpha.com/news/3308255-rough-day-for-hospital-names-evercore-mulls-medicare-reimbursement-cuts\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:55 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3308253\" data-ts=\"1509731125\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/QCOM\" target=\"_blank\">QCOM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3308253-qualcomm-up-after-rumor-of-broadcom-interest-update\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Qualcomm up after rumor of Broadcom interest (update)</a></h4><ul><li>Qualcomm (NASDAQ:<a href='https://seekingalpha.com/symbol/QCOM' title='Qualcomm Inc.'>QCOM</a>) shares are&nbsp;<font color='green'>up 5.58%</font>&nbsp;after rumors that Broadcom (NASDAQ:<a href='https://seekingalpha.com/symbol/AVGO' title='Broadcom Limited'>AVGO</a>) is exploring a deal to purchase the chipmaker.</li><li>Source: Bloomberg First Word</li><li>Broadcom shares are&nbsp;<font color='green'>up 3.17%.</font></li><li>Will update with more details if and when available.</li><li>Update: NXP Semiconductors (<a href='https://seekingalpha.com/symbol/NXPI' title='NXP Semiconductors'>NXPI</a> <font color='red'>-3.1%</font>) drops on the news. Qualcomm is in the process of acquiring NXP, a process held up by legal snags and activist investor pushes for a higher bid.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3307957-wsj-activist-investors-new-push-higher-nxp-semi-price\" target=\"_blank\">WSJ: Activist investor's new push for higher NXP Semi price</a> (Nov. 2)</li><li>Update: <a href=\"https://www.bloomberg.com/news/articles/2017-11-03/broadcom-is-said-to-explore-deal-to-acquire-chipmaker-qualcomm-j9k6u92n\" target=\"_blank\">Bloomberg's</a> sources say Broadcom could offer Qualcomm about $70 per share in cash and stock within the next few days.</li><li>Qualcomm shares are now&nbsp;<font color='green'>up 12.62%</font>&nbsp;to $61.76. Shares are&nbsp;<font color='red'>down nearly 16%&nbsp;</font>this year due to legal battles with Apple and the loss of royalties from Apple and an unnamed second licensee.</li></ul><div class=\"tiny-share-widget\" data-id=\"3308253\" data-linked=\"Qualcomm up after rumor of Broadcom interest (update)\" data-tweet=\"$QCOM $QCOM $AVGO - Qualcomm up after rumor of Broadcom interest (update) https://seekingalpha.com/news/3308253-qualcomm-up-after-rumor-of-broadcom-interest-update?source=tweet\" data-url=\"https://seekingalpha.com/news/3308253-qualcomm-up-after-rumor-of-broadcom-interest-update\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:45 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>232&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3308252\" data-ts=\"1509730847\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NE\" target=\"_blank\">NE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3308252-noble-corpminus-4-following-weak-q3-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Noble Corp. -4% following weak Q3 results</a></h4><ul>     <li>Noble Corp. (<a href='https://seekingalpha.com/symbol/NE' title='Noble Corporation plc'>NE</a> <font color='red'>-4.5%</font>) is sharply lower after reporting a sizeable <a href=\"https://seekingalpha.com/news/3307890-noble-corp-eps-line-misses-revenue\" target=\"_blank\">Q3 loss</a> and a 31% Y/Y revenue decline to $266M.</li>     <li>NE&nbsp;says Q3 utilization of its 14 jackup rigs was 81% vs. 93% in Q2, with the decline due primarily to a 6% decline in fleet operating days, as the <em>Noble Regina Allen</em>, <em>Noble Houston Colbert</em> and <em>Noble Mick O&rsquo;Brien</em> all completed contracts during the quarter.</li>     <li>Q3 utilization of the company&rsquo;s floating rig fleet of eight drillships and six semisubmersibles was 39% vs. 37% in Q2; average dayrates for Q3 were $253.3K vs. $273.7K in Q2.</li>     <li>NE's contract backlog, which totaled ~$3.2B at the end of Q3, has <a href=\"http://www.offshoreenergytoday.com/hurricane-harvey-deepens-nobles-3q-loss/\" target=\"_blank\">remained essentially flat throughout 2017</a> following the  addition of more than $800M in contracts through the quarter.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3308252\" data-linked=\"Noble Corp. -4% following weak Q3 results\" data-tweet=\"$NE - Noble Corp. -4% following weak Q3 results https://seekingalpha.com/news/3308252-noble-corpminus-4-following-weak-q3-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3308252-noble-corpminus-4-following-weak-q3-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:40 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3308251\" data-ts=\"1509730790\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RCII\" target=\"_blank\">RCII</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3308251-rent-center-confirms-receiving-takeover-offer\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Rent-A-Center confirms receiving takeover offer</a></h4><ul> <li>Rent-A-Center (<a href='https://seekingalpha.com/symbol/RCII' title='Rent-A-Center Inc.'>RCII</a> <font color='green'>+8.9%</font>) confirms that it received a conditional proposal from Vintage Capital       Management to acquire the company for $13.00 per share in cash.</li>     <li>The board says it will       carefully review and consider a full range of options focused on       maximizing stockholder value, which will now include the Vintage       proposal.</li>     <li>Source: <a href=\"https://seekingalpha.com/pr/16990874-rent-center-review-conditional-non-binding-proposal\" target=\"_blank\">Press Release</a></li><li>Previously: <a href=\"https://seekingalpha.com/news/3308133-rent-center-jumps-vintage-capital-makes-offer\" target=\"_blank\">Rent-A-Center jumps after Vintage Capital makes offer</a> (Nov. 3)</li></ul><div class=\"tiny-share-widget\" data-id=\"3308251\" data-linked=\"Rent-A-Center confirms receiving takeover offer\" data-tweet=\"$RCII - Rent-A-Center confirms receiving takeover offer https://seekingalpha.com/news/3308251-rent-center-confirms-receiving-takeover-offer?source=tweet\" data-url=\"https://seekingalpha.com/news/3308251-rent-center-confirms-receiving-takeover-offer\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:39 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3308250\" data-ts=\"1509730728\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WIFI\" target=\"_blank\">WIFI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3308250-boingo-wireless-up-13-after-q3-beats-upside-fy-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Boingo Wireless up 13% after Q3 beats, upside FY guidance</a></h4><ul><li>        Boingo Wireless (NASDAQ:<a href='https://seekingalpha.com/symbol/WIFI' title='Boingo Wireless'>WIFI</a>) shares are&nbsp;<font color='green'>up 13%</font>&nbsp;after yesterday&rsquo;s Q3 report beat EPS and revenue estimates and included upside guidance.</li><li>               FY17 guidance: revenue, $199M to $203M (consensus: $197.3M); EPS, -$0.66 to -$0.58 (consensus: -$0.62).&nbsp;</li><li>               Segment revenue: Wholesale Wi-Fi, $8.3M (+41.1%); Military, $13.9M (+37.6%); DAS, $21.8M (+36.3%).&nbsp;</li><li>               Key metrics: Adjusted EBITDA, $19.8M (+71.1%); net cash from operating activities, $20.1M; FCF, $2.7M.&nbsp;</li><li>               <a href=\"https://seekingalpha.com/pr/16989939-boingo-wireless-reports-record-third-quarter-2017-financial-results\" target=\"_blank\">Press release</a>&nbsp; &nbsp;&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3307791-boingo-wireless-beats-0_04-beats-revenue\" target=\"_blank\">Boingo Wireless beats by $0.04, beats on revenue</a> (Nov. 2)</li></ul><div class=\"tiny-share-widget\" data-id=\"3308250\" data-linked=\"Boingo Wireless up 13% after Q3 beats, upside FY guidance\" data-tweet=\"$WIFI - Boingo Wireless up 13% after Q3 beats, upside FY guidance https://seekingalpha.com/news/3308250-boingo-wireless-up-13-after-q3-beats-upside-fy-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3308250-boingo-wireless-up-13-after-q3-beats-upside-fy-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:38 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3308247\" data-ts=\"1509729574\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TTM\" target=\"_blank\">TTM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3308247-wsj-blackberry-in-software-talks-jaguar-land-rover\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">WSJ: BlackBerry in software talks with Jaguar Land Rover</a></h4><ul>   <li>BlackBerry (<a href=\"http://seekingalpha.com/symbol/BB\" target=\"_blank\">BB</a> <font color='green'>+2.2%</font>) is in <a href=\"https://www.wsj.com/articles/blackberry-in-talks-with-tata-motors-jaguar-land-rover-for-software-deal-1509728675?mod=yahoo_hs&amp;yptr=yahoo\" target=\"_blank\">advanced talks with Jaguar Land Rover</a> (<a href='https://seekingalpha.com/symbol/TTM' title='Tata Motors Limited'>TTM</a> <font color='green'>+1.5%</font>) to provide its software for next-generation vehicles, <em>The Wall Street Journal</em> reports.</li>    <li>The automaker would use the QNX software suite in building secure autonomous and electric vehicles, in an arrangement similar to the deal that BlackBerry has with Ford Motor.</li>    <li>It wouldn't result in immediate sales but generate revenue when the next-gen cars with QNX embedded go on sale, at a potential royalty of $25 per car depending on how many QNX modules are implemented.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3308247\" data-linked=\"WSJ: BlackBerry in software talks with Jaguar Land Rover\" data-tweet=\"$TTM $TTM $BB - WSJ: BlackBerry in software talks with Jaguar Land Rover https://seekingalpha.com/news/3308247-wsj-blackberry-in-software-talks-jaguar-land-rover?source=tweet\" data-url=\"https://seekingalpha.com/news/3308247-wsj-blackberry-in-software-talks-jaguar-land-rover\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:19 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>118&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3308244\" data-ts=\"1509729025\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ESNT\" target=\"_blank\">ESNT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3308244-mortgage-insurers-in-red-after-deutsche-bull-rings-register\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Mortgage insurers in the red after Deutsche bull rings the register</a></h4><ul><li>The \"bullish outlook\" for the names is reflected in their stock prices after big runs higher over the past few months, says analyst Phil Stefano, downgrading Essent Group (<a href='https://seekingalpha.com/symbol/ESNT' title='Essent Group Ltd.'>ESNT</a> <font color='red'>-4.7%</font>), MGIC Investment (<a href='https://seekingalpha.com/symbol/MTG' title='MGIC Investment Corporation'>MTG</a> <font color='red'>-4.9%</font>), Radian Group (<a href='https://seekingalpha.com/symbol/RDN' title='Radian Group, Inc.'>RDN</a> <font color='red'>-5%</font>), and NMI Holdings (<a href='https://seekingalpha.com/symbol/NMIH' title='NMI Holdings, Inc.'>NMIH</a> <font color='red'>-4.8%</font>) to Hold from Buy.</li><li>Year-to-date gains range from around 50% for NMIH to 15% for Radian.</li><li>Source: Bloomberg's Joshua Fineman</li></ul><div class=\"tiny-share-widget\" data-id=\"3308244\" data-linked=\"Mortgage insurers in the red after Deutsche bull rings the register\" data-tweet=\"$ESNT $ESNT $MTG - Mortgage insurers in the red after Deutsche bull rings the register https://seekingalpha.com/news/3308244-mortgage-insurers-in-red-after-deutsche-bull-rings-register?source=tweet\" data-url=\"https://seekingalpha.com/news/3308244-mortgage-insurers-in-red-after-deutsche-bull-rings-register\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:10 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3308242\" data-ts=\"1509728562\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3308242-financials-top-5-gainers-losers-of-1-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Financials - Top 5 Gainers / Losers as of 1:00 PM</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/GROW' title='U.S. Global Investors, Inc.'>GROW</a> <font color='green'>+25%</font>. <a href='https://seekingalpha.com/symbol/TRUP' title='Trupanion'>TRUP</a> <font color='green'>+14%</font>.<a href='https://seekingalpha.com/symbol/ECPG' title='Encore Capital Group Inc'>ECPG</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/HTGC' title='Hercules Capital, Inc.'>HTGC</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/ONDK' title='OnDeck Capital'>ONDK</a> <font color='green'>+6%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/FNGN' title='Financial Engines, Inc.'>FNGN</a> <font color='red'>-26%</font>. <a href='https://seekingalpha.com/symbol/CBL' title='CBL & Associates Properties, Inc.'>CBL</a> <font color='red'>-23%</font>. <a href='https://seekingalpha.com/symbol/RMAX' title='RE/MAX Holdings, Inc.'>RMAX</a> <font color='red'>-15%</font>. <a href='https://seekingalpha.com/symbol/NAVG' title='The Navigators Group, Inc.'>NAVG</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/WPG' title='Washington Prime Group, Inc.'>WPG</a> <font color='red'>-10%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3308242\" data-linked=\"Financials - Top 5 Gainers / Losers as of 1:00 PM\" data-tweet=\"$GROW $TRUP $ECPG - Financials - Top 5 Gainers / Losers as of 1:00 PM https://seekingalpha.com/news/3308242-financials-top-5-gainers-losers-of-1-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3308242-financials-top-5-gainers-losers-of-1-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:02 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3308239\" data-ts=\"1509728114\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GPRE\" target=\"_blank\">GPRE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3308239-green-plains-gets-upgrade-green-plains-partners-downgraded\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Green Plains gets an upgrade; Green Plains Partners downgraded</a></h4><ul>     <li>Green Plains (<a href='https://seekingalpha.com/symbol/GPRE' title='Green Plains Inc.'>GPRE</a> <font color='red'>-0.4%</font>) is <a href=\"https://thefly.com/thestreet/realmoney/index.php/GPREid2635401/GPRE-Green-Plains-upgraded-to-Overweight-from-Neutral-at-Piper-Jaffray\" target=\"_blank\">upgraded</a> to Overweight from Neutral with a $25 price target, raised from $19, at Piper Jaffray, which believes the market is undervaluing the company's \"less volatile\" non-ethanol assets.</li><li>Piper expects ethanol fundamentals will be positive next year, limiting downside to GPRE shares.</li>     <li>Meanwhile, Stifel analysts downgrade Green Plains Partners (<a href='https://seekingalpha.com/symbol/GPP' title='Green Plains Partners'>GPP</a> <font color='red'>-2.5%</font>) to Hold with a $20 price target, saying Q3  earnings were driven by weaker than expected rates on rail transportation and biodiesel volumes at Birmingham (source:&nbsp;Briefing.com).</li><li>Stifel says GPP's Jefferson Terminal is set to enter service in November, and it assumes  a dropdown will occur in Q1 2018, while the Little Rock Terminal secured permitting and is expected to be completed in Q1.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3308239\" data-linked=\"Green Plains gets an upgrade; Green Plains Partners downgraded\" data-tweet=\"$GPRE $GPRE $GPP - Green Plains gets an upgrade; Green Plains Partners downgraded https://seekingalpha.com/news/3308239-green-plains-gets-upgrade-green-plains-partners-downgraded?source=tweet\" data-url=\"https://seekingalpha.com/news/3308239-green-plains-gets-upgrade-green-plains-partners-downgraded\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:55 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3308238\" data-ts=\"1509727665\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3308238-midday-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday Gainers / Losers</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/DCIX' title='Diana Containerships Inc.'>DCIX</a> <font color='green'>+344%</font>. <a href='https://seekingalpha.com/symbol/ISIG' title='Insignia Systems, Inc.'>ISIG</a> <font color='green'>+40%</font>. <a href='https://seekingalpha.com/symbol/MYO' title='Myomo, Inc.'>MYO</a> <font color='green'>+36%</font>. <a href='https://seekingalpha.com/symbol/GROW' title='U.S. Global Investors, Inc.'>GROW</a> <font color='green'>+27%</font>. <a href='https://seekingalpha.com/symbol/VRNS' title='Varonis Systems Inc'>VRNS</a> <font color='green'>+22%</font>. <a href='https://seekingalpha.com/symbol/CERS' title='Cerus Corporation'>CERS</a> <font color='green'>+20%</font>. <a href='https://seekingalpha.com/symbol/PETX' title='Aratana Therapeutics'>PETX</a> <font color='green'>+19%</font>. <a href='https://seekingalpha.com/symbol/BOOT' title='Boot Barn Holdings'>BOOT</a> <font color='green'>+17%</font>. <a href='https://seekingalpha.com/symbol/DRAD' title='Digirad Corporation'>DRAD</a> <font color='green'>+17%</font>. <a href='https://seekingalpha.com/symbol/PODD' title='Insulet Corporation'>PODD</a> <font color='green'>+17%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/RUBI' title='The Rubicon Project, Inc.'>RUBI</a> <font color='red'>-39%</font>. <a href='https://seekingalpha.com/symbol/GNMK' title='GenMark Diagnostics, Inc.'>GNMK</a> <font color='red'>-36%</font>. <a href='https://seekingalpha.com/symbol/KEYW' title='KEYW Holding'>KEYW</a> <font color='red'>-35%</font>. <a href='https://seekingalpha.com/symbol/P' title='Pandora Media'>P</a> <font color='red'>-28%</font>. <a href='https://seekingalpha.com/symbol/HMSY' title='HMS Holdings Corp'>HMSY</a> <font color='red'>-24%</font>. <a href='https://seekingalpha.com/symbol/FNGN' title='Financial Engines, Inc.'>FNGN</a> <font color='red'>-25%</font>. <a href='https://seekingalpha.com/symbol/CBL' title='CBL & Associates Properties, Inc.'>CBL</a> <font color='red'>-24%</font>. <a href='https://seekingalpha.com/symbol/BVX' title='Bovie Medical Corporation'>BVX</a> <font color='red'>-21%</font>. <a href='https://seekingalpha.com/symbol/ENG' title='ENGlobal Corporation'>ENG</a> <font color='red'>-21%</font>. <a href='https://seekingalpha.com/symbol/PACB' title='Pacific Biosciences of California'>PACB</a> <font color='red'>-21%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3308238\" data-linked=\"Midday Gainers / Losers\" data-tweet=\"$DCIX $ISIG $MYO - Midday Gainers / Losers https://seekingalpha.com/news/3308238-midday-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3308238-midday-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:47 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3308237\" data-ts=\"1509726876\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VRTX\" target=\"_blank\">VRTX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3308237-vertexs-tezacaftor-ivacaftor-showed-significant-treatment-benefit-in-late-stage-studies\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Vertex&#39;s tezacaftor/ivacaftor showed significant treatment benefit in late-stage studies; shares ahead 3%</a></h4><ul><li>Vertex Pharmaceuticals (<a href='https://seekingalpha.com/symbol/VRTX' title='Vertex Pharmaceuticals Incorporated'>VRTX</a> <font color='green'>+3%</font>) perks up on light volume on the heels of its <a href=\"https://seekingalpha.com/pr/16990811-phase-3-studies-tezacaftor-ivacaftor-combination-treatment-people-cystic-fibrosis-ages-12\" target=\"_blank\">announcement </a>that positive results from two Phase 3 clinical trials assessing the combination of tezacaftor/ivacaftor in cystic fibrosis &#40;CF&#41; patients were just published in the <em>New England Journal of Medicine </em>and also presented at the 31st Annual North American Cystic Fibrosis Conference in Indianapolis, IN.</li><li>The EVOLVE trial evaluated the combination in CF patients who carried two copies of the F508del mutation while the EXPAND study enrolled those with one F508del mutation and one mutation that results in residual CFTR function (mutations in the CFTR gene cause CF).</li><li>Both studies demonstrated statistically valid improvements in lung function with favorable safety profiles. EVOLVE also showed a significant reduction in pulmonary exacerbations and lower body fat.</li><li>The company's marketing applications in the U.S. and Europe are currently under review. The FDA's action date is February 28.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3291596-marketing-applications-review-u-s-europe-vertexs-cf-combo-tezacaftor-ivacaftor-fda-action\" target=\"_blank\">Marketing applications under review in U.S. and Europe for Vertex's CF combo tezacaftor/ivacaftor, FDA action date February 28, 2018</a> (Aug. 24)</li></ul><div class=\"tiny-share-widget\" data-id=\"3308237\" data-linked=\"Vertex&#39;s tezacaftor/ivacaftor showed significant treatment benefit in late-stage studies; shares ahead 3%\" data-tweet=\"$VRTX - Vertex&#39;s tezacaftor/ivacaftor showed significant treatment benefit in late-stage studies; shares ahead 3% https://seekingalpha.com/news/3308237-vertexs-tezacaftor-ivacaftor-showed-significant-treatment-benefit-in-late-stage-studies?source=tweet\" data-url=\"https://seekingalpha.com/news/3308237-vertexs-tezacaftor-ivacaftor-showed-significant-treatment-benefit-in-late-stage-studies\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:34 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3308234\" data-ts=\"1509726178\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AIG\" target=\"_blank\">AIG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3308234-aig-down-4_7-sell-side-weighs-in-on-big-q3-miss\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AIG down 4.7%; Sell-side weighs in on big Q3 miss</a></h4><ul><li>via Bloomberg</li><li>BAML's Jay Cohen throws in the towel, downgrading to Neutral from Buy. The $836M reserve charge \"left us with limited confidence\" in the company's ability to \"accurately price its commercial insurance business.\"</li><li>Another challenging quarter reminds of <a href='https://seekingalpha.com/symbol/AIG' title='American International Group Inc'>AIG</a>'s \"long road to recovery,\" says Barclays' Jay Gelb. He continues to rate the stock Overweight, but cuts his PT to $68 from $71.</li><li>While the $3B catastrophe loss may have been expected, the $853M reserve build for prior year losses disproves his thesis that previous management left&nbsp; the P&amp;C business in better shape than they found it, says Credit Suisse's Ryan Tunis. If this was the last reserve charge, consensus estimates will prove to be conservative, but markets are in\"show me\" mode now. He rates the stock Outperform with $72 price target.</li><li>Buy the dip, says Wells Fargo bull Elyse Greenspan, as the reserve charge shows the company as working to improve its underwriting culture. New management, she says, will be successful in the turnaround, but it needs time. Her price target is $75.</li><li><a href=\"http://www.aig.com/content/dam/aig/america-canada/us/documents/investor-relations/2017/3q17-conference-call-presentation-11.02.2017.pdf\" target=\"_blank\">Earnings call presentation slides</a></li><li>Shares opened sharply lower and have stayed there, now&nbsp;<font color='red'>down 4.7%</font>.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3307789-aig-lower-2_3-percent-posting-big-loss\" target=\"_blank\">AIG lower by 2.3% after posting big loss</a> (Nov. 2)</li></ul><div class=\"tiny-share-widget\" data-id=\"3308234\" data-linked=\"AIG down 4.7%; Sell-side weighs in on big Q3 miss\" data-tweet=\"$AIG - AIG down 4.7%; Sell-side weighs in on big Q3 miss https://seekingalpha.com/news/3308234-aig-down-4_7-sell-side-weighs-in-on-big-q3-miss?source=tweet\" data-url=\"https://seekingalpha.com/news/3308234-aig-down-4_7-sell-side-weighs-in-on-big-q3-miss\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:22 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>20&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3308232\" data-ts=\"1509725660\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CC\" target=\"_blank\">CC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3308232-chemoursminus-10-investor-expectations-outstrip-reality-ubs-analyst-says\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Chemours -10% as investor expectations outstrip reality, UBS analyst says</a></h4><ul>     <li>Chemours (<a href='https://seekingalpha.com/symbol/CC' title='The Chemours Company'>CC</a> <font color='red'>-10.1%</font>) plunges as much as 12% despite reporting a solid <a href=\"https://seekingalpha.com/news/3307735-chemours-beats-0_08-beats-revenue\" target=\"_blank\">Q3 earnings</a> beat, as the quarter was considered a disappointment against &ldquo;relatively high&rdquo; expectations, says UBS chemical industry analyst John Roberts.</li>     <li>Q3 was the first time CC failed to report &ldquo;a blow-out upside&rdquo; in TiO2, and demand for base refrigerants is gradually declining and faces generic competition, Roberts says.</li>     <li>Still, Chemours is something of a <a href=\"https://www.wsj.com/articles/how-a-dupont-carve-out-made-a-comeback-1509722998\" target=\"_blank\">market darling</a>, as shares have more than tripled from the $16 spinout price in 2015 after briefly trading for less than $4 in 2016.</li>     <li>Source:&nbsp;Bloomberg First Word</li> </ul><div class=\"tiny-share-widget\" data-id=\"3308232\" data-linked=\"Chemours -10% as investor expectations outstrip reality, UBS analyst says\" data-tweet=\"$CC - Chemours -10% as investor expectations outstrip reality, UBS analyst says https://seekingalpha.com/news/3308232-chemoursminus-10-investor-expectations-outstrip-reality-ubs-analyst-says?source=tweet\" data-url=\"https://seekingalpha.com/news/3308232-chemoursminus-10-investor-expectations-outstrip-reality-ubs-analyst-says\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:14 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3308229\" data-ts=\"1509725315\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AHT\" target=\"_blank\">AHT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3308229-ashford-trustminus-7_5-after-results-revpar-flat-for-quarter\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ashford Trust -7.5% after results; RevPAR flat for quarter</a></h4><ul><li>Q3 adjusted FFO of $34.5M or $0.30 per share vs. $45.3M and $0.40 a year ago. Estimates were for $0.33.</li><li>Adjusted EBITDA of $100.8M down from $109.5M a year ago.</li><li>Comp RevPAR flat at $124.92; comp RevPAR excl. hotels not under renovation up 0.4% to $126.64.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3307752-ashford-hospitality-trust-misses-0_03-misses-revenue\" target=\"_blank\">Ashford Hospitality Trust misses by $0.03, misses on revenue</a> (Nov. 2)</li><li><a href='https://seekingalpha.com/symbol/AHT' title='Ashford Hospitality Trust, Inc.'>AHT</a><font color='red'> -7.5%</font></li></ul><div class=\"tiny-share-widget\" data-id=\"3308229\" data-linked=\"Ashford Trust -7.5% after results; RevPAR flat for quarter\" data-tweet=\"$AHT - Ashford Trust -7.5% after results; RevPAR flat for quarter https://seekingalpha.com/news/3308229-ashford-trustminus-7_5-after-results-revpar-flat-for-quarter?source=tweet\" data-url=\"https://seekingalpha.com/news/3308229-ashford-trustminus-7_5-after-results-revpar-flat-for-quarter\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:08 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3308228\" data-ts=\"1509724969\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SIRI\" target=\"_blank\">SIRI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3308228-pandoraminus-26_9-after-ad-trends-spook-analysts\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pandora -26.9% after ad trends spook analysts</a></h4><ul>   <li>After an earnings report where <a href=\"https://seekingalpha.com/news/3307845-pandora-minus-9_3-percent-q3-revenues-miss-mark\" target=\"_blank\">revenues disappointed</a> and advertising was flat, Pandora Media (<a href=\"http://seekingalpha.com/symbol/P\" target=\"_blank\">P</a> <font color='red'>-26.9%</font>) has shed a quarter of its market value today, hitting an all-time low of $5.37.</li>    <li>Bullish analysts have downgraded to Hold on the report. Stifel Nicolaus downgraded to Hold and trimmed its price target to $8 from $12, saying investors won't come back in until ad tech is better and audience trends normalize.</li>    <li>JPMorgan went to Neutral and a $9 price target. Needham's target is $8, and Cowen's is down to $6.</li>    <li>SunTrust cut to Hold and an $8 target (down from $10.50) after a \"sobering\" outlook from the company, noting its deficiencies in ad tech are more severe than thought. The company faces pressure in listener hours and in key brand advertising.</li>    <li>Morgan Stanley is a notable exception today, as its Benjamin Swinburne maintained an Overweight rating and $12 price target. <a href=\"https://www.benzinga.com/analyst-ratings/analyst-color/17/11/10281070/can-pandoras-new-management-team-change-analysts-tune\" target=\"_blank\">Outlook was \"light\" and ad trends are poor</a>, he notes, but the company has new management in CEO Roger Lynch, and a heavier hand from Sirius XM (NASDAQ:<a href='https://seekingalpha.com/symbol/SIRI' title='Sirius XM Holdings Inc.'>SIRI</a>) execs on the board.</li>    <li>\"We expect that these improvements will take time, that there is no silver bullet and that investors will likely have to wait until [the second half of 2018] to see initial fruits of new management's initiatives and investments,\" Swinburne writes.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3308228\" data-linked=\"Pandora -26.9% after ad trends spook analysts\" data-tweet=\"$SIRI $SIRI $P - Pandora -26.9% after ad trends spook analysts https://seekingalpha.com/news/3308228-pandoraminus-26_9-after-ad-trends-spook-analysts?source=tweet\" data-url=\"https://seekingalpha.com/news/3308228-pandoraminus-26_9-after-ad-trends-spook-analysts\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:02 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>38&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3308227\" data-ts=\"1509724852\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3308227-consumer-top-gainers-losers-of-12-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Consumer - Top Gainers / Losers as of 12:00 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/LBIX-OLD' title='Leading Brands Inc'>LBIX-OLD</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/FTFT' title='Future Fintech Group Inc'>FTFT</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/HY' title='Hyster-Yale Materials Handling, Inc.'>HY</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/UQM' title='UQM Technologies, Inc'>UQM</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/AXL' title='American Axle & Manufacturing Holdings, Inc.'>AXL</a> <font color='green'>+7%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/AVP' title='Avon Products, Inc.'>AVP</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/UEIC' title='Universal Electronics Inc.'>UEIC</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/CYRX' title='CryoPort, Inc.'>CYRX</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/ACU' title='Acme United Corporation'>ACU</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/STKL' title='SunOpta, Inc.'>STKL</a> <font color='red'>-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3308227\" data-linked=\"Consumer - Top Gainers / Losers as of 12:00 pm\" data-tweet=\"$LBIX-OLD $FTFT $HY - Consumer - Top Gainers / Losers as of 12:00 pm https://seekingalpha.com/news/3308227-consumer-top-gainers-losers-of-12-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3308227-consumer-top-gainers-losers-of-12-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3308225\" data-ts=\"1509724638\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CALD\" target=\"_blank\">CALD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3308225-callidus-software-up-11_8-after-q3-beats-in-line-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Callidus Software up 11.8% after Q3 beats, in-line guidance</a></h4><ul><li>        Callidus Software (NASDAQ:<a href='https://seekingalpha.com/symbol/CALD' title='Callidus Software, Inc.'>CALD</a>) shares are<font color='green'> up 11.76%</font>&nbsp;after yesterday&rsquo;s Q3 report beat revenue and EPS estimates and featured in-line guidance.</li><li>               Q4 guidance has revenue from $65M to $66M (consensus: $65.23M) while FY17 has $248.6M to $249.6M (consensus: $246.81).&nbsp;</li><li>               Preliminary 2018 guidance has revenue from $296M to $303M compared to the $293.93M consensus.&nbsp;</li><li>               Key metrics: SaaS revenue, $50.7M (+31% Y/Y); Maintenance revenue, $450K; Professional services revenue, $12.9M; cash and equivalents, $176.5M; cash flow from operations, $16.2M; recurring revenue gross margin, 77%; gross margin, 65%.&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3307739-callidus-software-beats-0_04-beats-revenue\" target=\"_blank\">Callidus Software beats by $0.04, beats on revenue</a> (Nov. 2)</li></ul><div class=\"tiny-share-widget\" data-id=\"3308225\" data-linked=\"Callidus Software up 11.8% after Q3 beats, in-line guidance\" data-tweet=\"$CALD - Callidus Software up 11.8% after Q3 beats, in-line guidance https://seekingalpha.com/news/3308225-callidus-software-up-11_8-after-q3-beats-in-line-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3308225-callidus-software-up-11_8-after-q3-beats-in-line-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:57 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3308219\" data-ts=\"1509724540\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMAG\" target=\"_blank\">AMAG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3308219-morgan-stanley-defends-amag-pharma-after-q3-miss-and-softer-guidance-stoked-selloff-shares-up\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Morgan Stanley defends AMAG Pharma after Q3 miss and softer guidance-stoked selloff; shares up 5%</a></h4><ul><li>AMAG Pharmaceuticals (<a href='https://seekingalpha.com/symbol/AMAG' title='AMAG Pharmaceuticals, Inc.'>AMAG</a> <font color='green'>+4.9%</font>) is clawing back from yesterday's&nbsp;<font color='red'>20%</font>&nbsp;high-volume plunge after it posted Q3 results that included a $13.6M revenue miss and downward revision to 2017 guidance.</li><li>In a note, Morgan Stanley's Thomas Smith says the selling was overdone considering Intrarosa's potential adding that investors headed for the exits based on weak Makena sales. He believes the stock's long-term value significantly exceeds today's (OVERWEIGHT/$22).</li><li>Source: Bloomberg</li><li>Previously: <a href=\"https://seekingalpha.com/news/3307251-amag-pharmaceuticals-eps-4_31\" target=\"_blank\">AMAG Pharmaceuticals EPS of -$4.31</a> (Nov. 2)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3307544-amag-pharmaceuticals-reports-q3-results-updates-guidance\" target=\"_blank\">AMAG Pharmaceuticals reports Q3 results; updates guidance</a> (Nov. 2)</li></ul><div class=\"tiny-share-widget\" data-id=\"3308219\" data-linked=\"Morgan Stanley defends AMAG Pharma after Q3 miss and softer guidance-stoked selloff; shares up 5%\" data-tweet=\"$AMAG - Morgan Stanley defends AMAG Pharma after Q3 miss and softer guidance-stoked selloff; shares up 5% https://seekingalpha.com/news/3308219-morgan-stanley-defends-amag-pharma-after-q3-miss-and-softer-guidance-stoked-selloff-shares-up?source=tweet\" data-url=\"https://seekingalpha.com/news/3308219-morgan-stanley-defends-amag-pharma-after-q3-miss-and-softer-guidance-stoked-selloff-shares-up\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:55 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3308217\" data-ts=\"1509723829\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CARB\" target=\"_blank\">CARB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3308217-carbonite-up-7_2-after-q3-beats-in-line-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Carbonite up 7.2% after Q3 beats, in-line guidance</a></h4><ul><li>        Carbonite (NASDAQ:<a href='https://seekingalpha.com/symbol/CARB' title='Carbonite Inc.'>CARB</a>) shares are&nbsp;<font color='green'>up 7.21%</font>&nbsp;after yesterday&rsquo;s Q3 report beat revenue and EPS estimates and provided mostly in-line guidance.</li><li>               Q4 guidance has revenue from $63M to $65M (consensus: $63.69M) with EPS from $0.27 to $0.31 (consensus: $0.32).&nbsp;</li><li>               Full-year 2017 guidance (narrowed): revenue, $246.3M to $248.3M (consensus: $245.47M; was $238.5M to $250.5M); EPS, $0.76 to $0.80 (consensus: $0.77; was $0.74 to $0.80).&nbsp;</li><li>               Key metrics: Bookings, $59.7M (+21% Y/Y); non-GAAP gross margin, 76.3% (+4.1%); cash flow from operations, $6.9M; adjusted FCF, $6M.&nbsp;</li><li>               <a href=\"https://seekingalpha.com/pr/16989977-carbonite-announces-third-quarter-2017-financial-results\" target=\"_blank\">Press release</a>&nbsp; &nbsp;&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3307768-carbonite-beats-0_04-beats-revenue\" target=\"_blank\">Carbonite beats by $0.04, beats on revenue</a> (Nov. 2)</li></ul><div class=\"tiny-share-widget\" data-id=\"3308217\" data-linked=\"Carbonite up 7.2% after Q3 beats, in-line guidance\" data-tweet=\"$CARB - Carbonite up 7.2% after Q3 beats, in-line guidance https://seekingalpha.com/news/3308217-carbonite-up-7_2-after-q3-beats-in-line-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3308217-carbonite-up-7_2-after-q3-beats-in-line-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:43 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3308216\" data-ts=\"1509723693\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ALNY\" target=\"_blank\">ALNY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3308216-interim-data-on-alnylams-lumasiran-show-positive-effect-in-ph1-patients-shares-ahead-2\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Interim data on Alnylam&#39;s lumasiran show positive effect in PH1 patients; shares ahead 2%</a></h4><ul><li><a href=\"https://seekingalpha.com/pr/16990841-alnylam-reports-positive-preliminary-results-ongoing-phase-1-2-study-lumasiran-aln-go1\" target=\"_blank\">Preliminary results</a> from a Phase 1/2 clinical trial assessing Alnylam Pharmaceuticals' (<a href='https://seekingalpha.com/symbol/ALNY' title='Alnylam Pharmaceuticals, Inc.'>ALNY</a> <font color='green'>+1.5%</font>) lumasiran (ALN-GO1) in patients with <a href=\"https://rarediseases.info.nih.gov/diseases/2835/primary-hyperoxaluria-type-1\" target=\"_blank\">primary hyperoxaluria type 1</a> (PH1) showed a treatment effect. The data were presented at Kidney Week in New Orleans, LA.</li><li>Three patients in the first cohort who received monthly doses of lumasiran (1 mg/kg) for three months experienced more than 50% decreases in urinary oxalate excretion from baseline.</li><li>Results from the second cohort (monthly doses of 3 mg/kg or placebo for three months) remain blinded.</li><li>Lumasiran is an RNAi therapeutic that targets a liver enzyme called glycolate oxidase &#40;GO&#41;. Reducing GO depletes the substrate for oxalate production which contributes to the pathology of PH1, a rare inherited disorder affecting the kidneys. Excess oxalate combines with calcium to form kidney and bladder stones (calcium oxalate).</li></ul><div class=\"tiny-share-widget\" data-id=\"3308216\" data-linked=\"Interim data on Alnylam&#39;s lumasiran show positive effect in PH1 patients; shares ahead 2%\" data-tweet=\"$ALNY - Interim data on Alnylam&#39;s lumasiran show positive effect in PH1 patients; shares ahead 2% https://seekingalpha.com/news/3308216-interim-data-on-alnylams-lumasiran-show-positive-effect-in-ph1-patients-shares-ahead-2?source=tweet\" data-url=\"https://seekingalpha.com/news/3308216-interim-data-on-alnylams-lumasiran-show-positive-effect-in-ph1-patients-shares-ahead-2\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:41 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3308215\" data-ts=\"1509723630\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TWX\" target=\"_blank\">TWX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3308215-pursuing-1b-digital-revenues-cnn-to-offer-news-subscriptions\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pursuing $1B digital revenues, CNN to offer news subscriptions</a></h4><ul>   <li>As part of an ongoing turnaround to digital, CNN (<a href=\"http://seekingalpha.com/symbol/TWX\" target=\"_blank\">TWX</a> <font color='red'>-1.8%</font>) is planning to offer <a href=\"https://www.wsj.com/articles/cnn-plans-to-offer-subscriptions-for-digital-news-next-year-1509701401\" target=\"_blank\">tiered news subscriptions</a> as soon as Q2.</li>    <li>Pricing is in the early stages, but digital news subscriptions could be built around content verticals like CNN Money and CNN Politics as the news network pursues new revenue streams.</li>    <li>It has a goal of reaching $1B in digital revenue by 2022; a source tells WSJ that the digital operation will draw $370M this year, with most money coming from pre-roll advertising on videos.</li>    <li>CNN has more than 600 digital-focused employees.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3308215\" data-linked=\"Pursuing $1B digital revenues, CNN to offer news subscriptions\" data-tweet=\"$TWX - Pursuing $1B digital revenues, CNN to offer news subscriptions https://seekingalpha.com/news/3308215-pursuing-1b-digital-revenues-cnn-to-offer-news-subscriptions?source=tweet\" data-url=\"https://seekingalpha.com/news/3308215-pursuing-1b-digital-revenues-cnn-to-offer-news-subscriptions\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:40 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3308213\" data-ts=\"1509722725\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VRNS\" target=\"_blank\">VRNS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3308213-varonis-systems-up-19_7-after-q3-beat-upside-q4-and-fy-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Varonis Systems up 19.7% after Q3 beat, upside Q4 and FY guidance</a></h4><ul><li>        Varonis Systems (NASDAQ:<a href='https://seekingalpha.com/symbol/VRNS' title='Varonis Systems Inc'>VRNS</a>) shares are&nbsp;<font color='green'>up 19.7%</font>&nbsp;after yesterday&rsquo;s Q3 earnings beat EPS and revenue estimates with an upside Q4 guidance.</li><li>               The company expects Q4 revenue from $65.5M to $67M (consensus: $65.18M) and EPS from $0.28 to $0.29 (consensus: $0.27).&nbsp;</li><li>               FY17 guidance has revenue from $209.5M to $211M (consensus: $206.3M) and EPS from $0.16 to $0.17 (consensus: $0.09).&nbsp;</li><li>               <a href=\"https://seekingalpha.com/pr/16990011-varonis-announces-third-quarter-2017-financial-results\" target=\"_blank\">Press release</a>&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3307788-varonis-beats-0_06-beats-revenue\" target=\"_blank\">Varonis beats by $0.06, beats on revenue</a> (Nov. 2)</li></ul><div class=\"tiny-share-widget\" data-id=\"3308213\" data-linked=\"Varonis Systems up 19.7% after Q3 beat, upside Q4 and FY guidance\" data-tweet=\"$VRNS - Varonis Systems up 19.7% after Q3 beat, upside Q4 and FY guidance https://seekingalpha.com/news/3308213-varonis-systems-up-19_7-after-q3-beat-upside-q4-and-fy-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3308213-varonis-systems-up-19_7-after-q3-beat-upside-q4-and-fy-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:25 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3308206\" data-ts=\"1509721922\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CORT\" target=\"_blank\">CORT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3308206-corcepts-q3-revenue-beat-and-guidance-raise-not-enough-to-boost-shares-down-8\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Corcept&#39;s Q3 revenue beat and guidance raise not enough to boost shares, down 8%</a></h4><ul><li>Corcept Therapeutics (<a href='https://seekingalpha.com/symbol/CORT' title='Corcept Therapeutics Incorporated'>CORT</a> <font color='red'>-7.6%</font>) is down on modestly higher volume in response to its <a href=\"https://seekingalpha.com/pr/16990032-corcept-therapeutics-announces-third-quarter-2017-financial-results-raises-2017-revenue\" target=\"_blank\">Q3 numbers</a> released after the close yesterday.</li><li>EPS was in line with consensus while revenue came in slightly above driven by strong <a href=\"http://www.corcept.com/korlym.html\" target=\"_blank\">Korlym </a>(mifepristone) sales.</li><li>Revenues: $42.8M (+97.2%); Net Income: $13.7M (+426.9%); Non-GAAP Net Income: $17.4M (+286.7%); EPS: $0.11 (+450.0%); Non-GAAP EPS: $0.14 (+250.0%).</li><li><strong>2017 Guidance</strong>: Revenue: $157M - 162M from $145M - 155M.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3307774-corcept-therapeutics-eps-line-beats-revenue\" target=\"_blank\">Corcept Therapeutics EPS in-line, beats on revenue</a> (Nov. 2)</li></ul><div class=\"tiny-share-widget\" data-id=\"3308206\" data-linked=\"Corcept&#39;s Q3 revenue beat and guidance raise not enough to boost shares, down 8%\" data-tweet=\"$CORT - Corcept&#39;s Q3 revenue beat and guidance raise not enough to boost shares, down 8% https://seekingalpha.com/news/3308206-corcepts-q3-revenue-beat-and-guidance-raise-not-enough-to-boost-shares-down-8?source=tweet\" data-url=\"https://seekingalpha.com/news/3308206-corcepts-q3-revenue-beat-and-guidance-raise-not-enough-to-boost-shares-down-8\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:12 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3308203\" data-ts=\"1509721366\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CBL\" target=\"_blank\">CBL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3308203-shopping-center-mall-names-shudder-cbl-plunges\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Shopping center/mall names shudder as CBL plunges</a></h4><ul><li>The already badly-bruised market cap of CBL &amp; Associates (NYSE:<a href='https://seekingalpha.com/symbol/CBL' title='CBL & Associates Properties, Inc.'>CBL</a>) has seen&nbsp;<font color='red'>another 25% wiped away</font>&nbsp;today following <a href=\"https://seekingalpha.com/news/3308092-cbl-crumbles-20-percent-earnings-miss-guidance-cut-slash-dividend\" target=\"_blank\">a Q3 miss</a>, and a cut in guidance and the dividend alongside.</li><li>It's clear discussions between retailers and landlords have become more challenged for \"B/C\" malls, says BAML's Craig Schmidt, downgrading CBL to Underperform. He notes that while portfolio occupancy fell Y/Y, it rose sharply sequentially, suggesting to him that the company offered significant concessions.</li><li>Sluggish results and the dividend cut should \"scare investors,\" says Boenning's&nbsp;Floris van Dijkum, downgrading to Underperform. He does upgrade Tanger Factor (NYSE:<a href='https://seekingalpha.com/symbol/SKT' title='Tanger Factory Outlet Centers, Inc.'>SKT</a>) to Neutral from Underperform. No help, Tanger is&nbsp;<font color='red'>down 5.8%</font>.</li><li>Analyst comments via Bloomberg</li><li>Other players: Taubman Centers (<a href='https://seekingalpha.com/symbol/TCO' title='Taubman Centers, Inc.'>TCO</a> <font color='red'>-5.1%</font>), DDR (DDR <font color='red'>-4%</font>), PREIT (<a href='https://seekingalpha.com/symbol/PEI' title='Pennsylvania Real Estate Investment Trust'>PEI</a> <font color='red'>-5.7%</font>), Washington Prime (<a href='https://seekingalpha.com/symbol/WPG' title='Washington Prime Group, Inc.'>WPG</a> <font color='red'>-9.5%</font>), Wheeler Real Estate (<a href='https://seekingalpha.com/symbol/WHLR' title='Wheeler Real Estate Investment Trust'>WHLR</a> <font color='red'>-2.9%</font>), Kite Realty (<a href='https://seekingalpha.com/symbol/KRG' title='Kite Realty Group Trust'>KRG</a> <font color='red'>-1.8%</font>), Federal Realty (<a href='https://seekingalpha.com/symbol/FRT' title='Federal Realty Investment Trust'>FRT</a> <font color='red'>-1.2%</font>), Kimco (<a href='https://seekingalpha.com/symbol/KIM' title='Kimco Realty Corporation'>KIM</a> <font color='red'>-1.2%</font>).</li><li>\"A\" malls are no place to hide today: Simon Property (<a href='https://seekingalpha.com/symbol/SPG' title='Simon Property Group, Inc.'>SPG</a> <font color='red'>-2.3%</font>), GGP (GGP <font color='red'>-2.6%</font>), Macerich (<a href='https://seekingalpha.com/symbol/MAC' title='Macerich Co.'>MAC</a> <font color='red'>-4.2%</font>)</li></ul><div class=\"tiny-share-widget\" data-id=\"3308203\" data-linked=\"Shopping center/mall names shudder as CBL plunges\" data-tweet=\"$CBL $CBL $SKT - Shopping center/mall names shudder as CBL plunges https://seekingalpha.com/news/3308203-shopping-center-mall-names-shudder-cbl-plunges?source=tweet\" data-url=\"https://seekingalpha.com/news/3308203-shopping-center-mall-names-shudder-cbl-plunges\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:02 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>183&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3308171\" data-ts=\"1509721328\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3308171-healthcare-top-5-gainers-losers-of-11-00\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Healthcare - Top 5 Gainers / Losers as of 11:00 am</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/CERS' title='Cerus Corporation'>CERS</a> <font color='green'>+18%</font>. <a href='https://seekingalpha.com/symbol/PODD' title='Insulet Corporation'>PODD</a> <font color='green'>+17%</font>. <a href='https://seekingalpha.com/symbol/BIO' title='Bio-Rad Laboratories, Inc.'>BIO</a> <font color='green'>+16%</font>. <a href='https://seekingalpha.com/symbol/ABUS' title='Arbutus Biopharma Corp'>ABUS</a> <font color='green'>+16%</font>. <a href='https://seekingalpha.com/symbol/MOH' title='Molina Healthcare, Inc.'>MOH</a> <font color='green'>+15%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/GNMK' title='GenMark Diagnostics, Inc.'>GNMK</a> <font color='red'>-36%</font>. <a href='https://seekingalpha.com/symbol/NSTG' title='NanoString Technologies'>NSTG</a> <font color='red'>-21%</font>. <a href='https://seekingalpha.com/symbol/BVX' title='Bovie Medical Corporation'>BVX</a> <font color='red'>-20%</font>. <a href='https://seekingalpha.com/symbol/PACB' title='Pacific Biosciences of California'>PACB</a> <font color='red'>-17%</font>. <a href='https://seekingalpha.com/symbol/VYGR' title='Voyager Therapeutics'>VYGR</a> <font color='red'>-10%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3308171\" data-linked=\"Healthcare - Top 5 Gainers / Losers as of 11:00 am\" data-tweet=\"$CERS $PODD $BIO - Healthcare - Top 5 Gainers / Losers as of 11:00 am https://seekingalpha.com/news/3308171-healthcare-top-5-gainers-losers-of-11-00?source=tweet\" data-url=\"https://seekingalpha.com/news/3308171-healthcare-top-5-gainers-losers-of-11-00\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:02 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3308202\" data-ts=\"1509721313\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AQ\" target=\"_blank\">AQ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3308202-aquantia-up-8-in-debut-after-pricing-below-range\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Aquantia up 8% in debut after pricing below range</a></h4><ul>   <li>Communications chipmaker Aquantia (<a href=\"http://seekingalpha.com/symbol/AQ\" target=\"_blank\">AQ</a> <font color='green'>+7.9%</font>) has opened for trading, above its IPO price.</li>    <li>Shares are at $9.71 after <a href=\"https://seekingalpha.com/news/3307971-aquantia-prices-ipo-range-9-share\" target=\"_blank\">pricing last night at $9</a> -- which had come out below a marketed range of $10-$12.</li>    <li>The company offered 6.81M shares in the IPO.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3308202\" data-linked=\"Aquantia up 8% in debut after pricing below range\" data-tweet=\"$AQ - Aquantia up 8% in debut after pricing below range https://seekingalpha.com/news/3308202-aquantia-up-8-in-debut-after-pricing-below-range?source=tweet\" data-url=\"https://seekingalpha.com/news/3308202-aquantia-up-8-in-debut-after-pricing-below-range\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:01 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3308197\" data-ts=\"1509720916\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VWDRY\" target=\"_blank\">VWDRY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3308197-european-wind-turbine-makers-plunge-on-u-s-tax-proposal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">European wind turbine makers plunge on U.S. tax proposal</a></h4><ul>     <li>Shares in Vestas Wind (<a href='https://seekingalpha.com/symbol/VWDRY' title='Vestas Wind Systems A/S ADR'>OTCPK:VWDRY</a> <font color='red'>-8.5%</font>) and other <a href=\"http://www.nasdaq.com/article/wind-turbine-makers-fall-on-republican-tax-bill-proposal-20171103-00205\" target=\"_blank\">European wind turbine makers are tumbling</a> today in reaction to proposed cuts to renewable energy that are part of the proposed Republican tax bill, threatening the group's expansion in the U.S. market.</li>     <li>Shares in Vestas, Siemens (<a href='https://seekingalpha.com/symbol/SIEGY' title='Siemens AG ADR'>OTCPK:SIEGY</a> <font color='red'>-1.1%</font>), Siemens Gamesa (<a href='https://seekingalpha.com/symbol/GCTAF' title='Siemens Gamesa Renewable Energy'>OTCPK:GCTAF</a> <font color='red'>-3.7%</font>) and Germany's Nordex (<a href='https://seekingalpha.com/symbol/NRDXF' title='Nordex AG'>OTCPK:NRDXF</a>) all are lower in European trading.</li>     <li>\"The proposed House tax bill could have detrimental effects on market volumes and prices if passed; at best Wind stocks face increased near-term uncertainty,\" according to Barclays analysts, adding Vestas and Siemens Gamesa shares should be most affected.</li></ul><div class=\"tiny-share-widget\" data-id=\"3308197\" data-linked=\"European wind turbine makers plunge on U.S. tax proposal\" data-tweet=\"$VWDRY $VWDRY $SIEGY - European wind turbine makers plunge on U.S. tax proposal https://seekingalpha.com/news/3308197-european-wind-turbine-makers-plunge-on-u-s-tax-proposal?source=tweet\" data-url=\"https://seekingalpha.com/news/3308197-european-wind-turbine-makers-plunge-on-u-s-tax-proposal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:55 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>18&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3308190\" data-ts=\"1509719712\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VMW\" target=\"_blank\">VMW</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3308190-vmware-will-acquire-sd-wan-provider\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">VMware will acquire SD-WAN provider</a></h4><ul><li>        VMware (NYSE:<a href='https://seekingalpha.com/symbol/VMW' title='VMware, Inc.'>VMW</a>) will <a href=\"https://seekingalpha.com/pr/16988551-vmware-charts-networkings-software-defined-future-enterprises-service-providers-intent\" target=\"_blank\">acquire</a> VeloCloud, a provider of cloud-based software-defined-wide-area network &#40;SD-WAN&#41; technology.</li><li>               VeloCloud has more than 1K customers including AT&amp;T, Sprint, and Vonage.&nbsp;</li><li>               Terms not disclosed but the transaction should close in VMware&rsquo;s Q4FY18. The acquisition won&rsquo;t change the company&rsquo;s FY18 guidance.&nbsp;</li><li>VMware shares are&nbsp;<font color='red'>down 1.04%</font>.&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3295464-barclays-upgrades-vmware-ups-price-target\" target=\"_blank\">Barclays upgrades VMware, ups price target</a> (Sept. 14)</li></ul><div class=\"tiny-share-widget\" data-id=\"3308190\" data-linked=\"VMware will acquire SD-WAN provider\" data-tweet=\"$VMW - VMware will acquire SD-WAN provider https://seekingalpha.com/news/3308190-vmware-will-acquire-sd-wan-provider?source=tweet\" data-url=\"https://seekingalpha.com/news/3308190-vmware-will-acquire-sd-wan-provider\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:35 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3308186\" data-ts=\"1509718934\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AGO\" target=\"_blank\">AGO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3308186-assured-guaranty-up-4-post-earnings-bull-boosts-price-target\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Assured Guaranty up 4% post-earnings; bull boosts price target</a></h4><ul><li>The company did have to post a sizable $233M to loss reserves mostly thanks to Puerto Rican exposure, but underlying solid operating results and growing adjusted book value in the face of difficult circumstances is the story, <a href=\"http://researchwiseny.btig.com/ResearchLibraryAnalec/DownloadResearch.aspx?E=badaak-b\" target=\"_blank\">says BTIG's Mark Palmer</a>.</li><li>Non-GAAP adjusted book value rose to $74.78 from $73.48 three months earlier. Buybacks totaled $80M in Q3, and the company this month authorized another $300M.</li><li>Palmer lifts his price target by $1 to $50, which represents 0.65x estimated year-end 2018 adjusted book value, minus $3.82 per share for PR exposure.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3307900-assured-guaranty-eps-1_29\" target=\"_blank\">Assured Guaranty EPS of $1.29</a> (Nov. 2)</li><li><a href='https://seekingalpha.com/symbol/AGO' title='Assured Guaranty Ltd.'>AGO</a>&nbsp;<font color='green'>+4.15%</font>&nbsp;to $38.42</li></ul><div class=\"tiny-share-widget\" data-id=\"3308186\" data-linked=\"Assured Guaranty up 4% post-earnings; bull boosts price target\" data-tweet=\"$AGO - Assured Guaranty up 4% post-earnings; bull boosts price target https://seekingalpha.com/news/3308186-assured-guaranty-up-4-post-earnings-bull-boosts-price-target?source=tweet\" data-url=\"https://seekingalpha.com/news/3308186-assured-guaranty-up-4-post-earnings-bull-boosts-price-target\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:22 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3308185\" data-ts=\"1509718862\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/APRN\" target=\"_blank\">APRN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3308185-blue-apron-falls-to-new-post-ipo-low\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Blue Apron falls to new post-IPO low</a></h4><ul> <li>Blue Apron (NYSE:<a href='https://seekingalpha.com/symbol/APRN' title='Blue Apron Holdings, Inc.'>APRN</a>) is <font color='red'>down 4.21%</font> and traded earlier at a post-IPO low of $3.56. The market cap on the online meal kit provider is now below $700M.</li> <li>Wall Street analysts aren't looking too strong right now after recommending the stock. Needham (Buy, $5 price target) believes Blue Apron could be an acquisition target, while RBC Capital (Outperform, $6 PT) is pointing all the way out to 2019 for a recovery.</li> <li>Peer watch: Hello Fresh (<a href='https://seekingalpha.com/symbol/FRESH' title='HelloFresh'>FRESH</a>) started trading this week on the Frankfurt Stock Exchange. In <a href=\"https://www.recode.net/2017/11/2/16598114/hellofresh-ipo-blue-apron-comparison-worth-revenue\" target=\"_blank\">Q2</a>, Hello Fresh grew sales 53% to easily outpace the 18% sales growth recorded by Blue Apron.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3308185\" data-linked=\"Blue Apron falls to new post-IPO low\" data-tweet=\"$APRN $APRN $FRESH - Blue Apron falls to new post-IPO low https://seekingalpha.com/news/3308185-blue-apron-falls-to-new-post-ipo-low?source=tweet\" data-url=\"https://seekingalpha.com/news/3308185-blue-apron-falls-to-new-post-ipo-low\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:21 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>22&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3308184\" data-ts=\"1509718746\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SSP\" target=\"_blank\">SSP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3308184-scripps-slides-6_5-swings-to-losses\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Scripps slides 6.5% as it swings to losses</a></h4><ul>   <li>E.W. Scripps (NASDAQ:<a href='https://seekingalpha.com/symbol/SSP' title='The E.W. Scripps Company'>SSP</a>) has <font color='red'>slid 6.5%</font> after posting a <a href=\"https://seekingalpha.com/news/3308083-e-w-scripps-beats-0_02-misses-revenue\" target=\"_blank\">Q3 earnings report</a> where revenues declined and missed and expenses rose, sending the company to an operating loss.</li>    <li>Net loss was $26.7M vs. a year-ago gain of $12.5M. The company did take a $35.7M impairment charge for Cracked, the humor brand it acquired last fall.</li>    <li>Retransmission revenues were a bright spot, rising 20% to $64M after two contracts were renewed at higher rates.</li>    <li>Revenues by segment: Television, $179.9M (down 8.8%); Radio, $17.9M (down 7.4%); Digital, $17.85M (up 13.3%); Other, $814,000 (up 16%).</li>    <li>Profit by segment: Television, $32.1M (down 45%); Radio, $1.5M (down 40.3%); Digital, -$5.7M; Other, -$897,000.</li>    <li>For Q4, it's guiding to TV revenues slipping in the high teens, with radio revenue down in high single digits. Digital revenues are seen around $60M, with digital expense in the mid- to high $50M range.</li>    <li><a href=\"https://seekingalpha.com/pr/16990536-scripps-reports-third-quarter-2017-results\" target=\"_blank\">Press Release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3308184\" data-linked=\"Scripps slides 6.5% as it swings to losses\" data-tweet=\"$SSP - Scripps slides 6.5% as it swings to losses https://seekingalpha.com/news/3308184-scripps-slides-6_5-swings-to-losses?source=tweet\" data-url=\"https://seekingalpha.com/news/3308184-scripps-slides-6_5-swings-to-losses\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:19 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3308183\" data-ts=\"1509718734\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SYNA\" target=\"_blank\">SYNA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3308183-rosenblatt-downgrades-synaptics\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Rosenblatt downgrades Synaptics</a></h4><ul><li>        Rosenblatt <a href=\"http://www.briefing.com/DisplayArticle/ArticlePopup.aspx?ArticleId=IN20171103073531SYNA\" target=\"_blank\">downgrades</a> Synaptics (NASDAQ:<a href='https://seekingalpha.com/symbol/SYNA' title='Synaptics Incorporated'>SYNA</a>) from Buy to Neutral.</li><li>                  Latest analyst standings (via <a href=\"https://markets.ft.com/data/equities/tearsheet/forecasts?s=SYNA:NSQ\" target=\"_blank\">FT</a>): 3 Buy, 6 Outperform, 5 Hold, and 2 Sell.    </li><li>               Median price target: $55.&nbsp;</li><li>               Synaptics shares are&nbsp;<font color='red'>down 4.31%</font>.&nbsp;&nbsp;&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3299927-mizuho-downgrades-synaptics-cites-misplaced-optimism-tddi\" target=\"_blank\">Mizuho downgrades Synaptics, cites misplaced optimism on TDDI</a> (Oct. 9)</li></ul><div class=\"tiny-share-widget\" data-id=\"3308183\" data-linked=\"Rosenblatt downgrades Synaptics\" data-tweet=\"$SYNA - Rosenblatt downgrades Synaptics https://seekingalpha.com/news/3308183-rosenblatt-downgrades-synaptics?source=tweet\" data-url=\"https://seekingalpha.com/news/3308183-rosenblatt-downgrades-synaptics\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:18 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3308180\" data-ts=\"1509718641\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GNMK\" target=\"_blank\">GNMK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3308180-genmark-diagnostics-q3-miss-sinks-shares-down-31\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">GenMark Diagnostics Q3 miss sinks shares, down 31%</a></h4><ul><li>Thinly traded micro cap GenMark Diagnostics (<a href='https://seekingalpha.com/symbol/GNMK' title='GenMark Diagnostics, Inc.'>GNMK</a> <font color='red'>-31.4%</font>) is getting roughed up in early trading after posting <a href=\"https://seekingalpha.com/pr/16989963-genmark-diagnostics-reports-third-quarter-2017-results\" target=\"_blank\">Q3 results</a> after the close yesterday. Revenue was almost $3M shy of consensus.</li><li>Revenue: $11.6M (+8.4%); Net Loss: ($15.4M) (-27.3%).</li><li><strong>2017 Guidance</strong>: Revenue: $51M - 53M; 185 - 200 ePlex placements.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3307694-genmark-diagnostics-misses-0_03-misses-revenue\" target=\"_blank\">GenMark Diagnostics misses by $0.03, misses on revenue</a> (Nov. 2)</li></ul><div class=\"tiny-share-widget\" data-id=\"3308180\" data-linked=\"GenMark Diagnostics Q3 miss sinks shares, down 31%\" data-tweet=\"$GNMK - GenMark Diagnostics Q3 miss sinks shares, down 31% https://seekingalpha.com/news/3308180-genmark-diagnostics-q3-miss-sinks-shares-down-31?source=tweet\" data-url=\"https://seekingalpha.com/news/3308180-genmark-diagnostics-q3-miss-sinks-shares-down-31\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:17 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3308179\" data-ts=\"1509718255\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BOOT\" target=\"_blank\">BOOT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3308179-boot-barn-soars-after-strong-results-in-hurricane-influenced-quarter\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Boot Barn soars after strong results in hurricane-influenced quarter</a></h4><ul> <li>Boot Barn (NASDAQ:<a href='https://seekingalpha.com/symbol/BOOT' title='Boot Barn Holdings'>BOOT</a>) <font color='green'>runs up 19%</font> after topping estimates on both lines of its FQ2 report and lifting guidance.</li> <li>The retailer now sees FY18 EPS of $0.57 to $0.61 vs. $0.57 consensus.</li> <li>Same-store sales were up 1.8%, despite the disruption to business from the U.S. hurricanes. The company ended the quarter with inventory down 1% on a per store basis.</li> <li>Shares of Boot Barn are threatening to trade over $10 for the first time since May.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3307771-boot-barn-beats-0_02-beats-revenue\" target=\"_blank\">Boot Barn beats by $0.02, beats on revenue</a> (Nov. 2)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3308179\" data-linked=\"Boot Barn soars after strong results in hurricane-influenced quarter\" data-tweet=\"$BOOT - Boot Barn soars after strong results in hurricane-influenced quarter https://seekingalpha.com/news/3308179-boot-barn-soars-after-strong-results-in-hurricane-influenced-quarter?source=tweet\" data-url=\"https://seekingalpha.com/news/3308179-boot-barn-soars-after-strong-results-in-hurricane-influenced-quarter\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:10 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3308178\" data-ts=\"1509718179\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CTXS\" target=\"_blank\">CTXS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3308178-goldman-sachs-upgrades-citrix-systems\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Goldman Sachs upgrades Citrix Systems</a></h4><ul><li>        Goldman Sachs upgrades Citrix Systems (NASDAQ:<a href='https://seekingalpha.com/symbol/CTXS' title='Citrix Systems, Inc.'>CTXS</a>) from Neutral to Buy.</li><li>               Latest analyst standings (via <a href=\"https://markets.ft.com/data/equities/tearsheet/forecasts?s=CTXS:NSQ\" target=\"_blank\">FT</a>): 5 Buy, 4 Outperform, 12 Hold, 1 Underperform, 2 Sell.&nbsp;</li><li>               Median price target: $90. &nbsp;&nbsp;</li><li>               Citrix Systems shares are&nbsp;<font color='green'>up 3.25%</font>.&nbsp;&nbsp;&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3304199-citrix-nearly-3-percent-following-q3-results\" target=\"_blank\">Citrix down nearly 3% following Q3 results</a> (Oct. 25)</li></ul><div class=\"tiny-share-widget\" data-id=\"3308178\" data-linked=\"Goldman Sachs upgrades Citrix Systems\" data-tweet=\"$CTXS - Goldman Sachs upgrades Citrix Systems https://seekingalpha.com/news/3308178-goldman-sachs-upgrades-citrix-systems?source=tweet\" data-url=\"https://seekingalpha.com/news/3308178-goldman-sachs-upgrades-citrix-systems\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:09 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3308175\" data-ts=\"1509717914\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PODD\" target=\"_blank\">PODD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3308175-insulet-q3-beat-and-guidance-raise-propel-shares-up-17\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Insulet Q3 beat and guidance raise propel shares, up 17%</a></h4><ul><li>Insulet (<a href='https://seekingalpha.com/symbol/PODD' title='Insulet Corporation'>PODD</a> <font color='green'>+16.6%</font>) is up in early trading after reporting <a href=\"https://seekingalpha.com/pr/16989891-insulet-reports-third-quarter-2017-financial-results\" target=\"_blank\">Q3 results</a> yesterday after the close. Revenues came in over $7M above consensus.</li><li>Revenue: $121.8M (+28.3%); Net Loss: ($2.2M) (+27.7%); Loss/Share: ($0.04) (+20.0%).</li><li><strong>2017 Guidance</strong>: Revenues: $456M - 459M from $440M - 450M.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3307731-insulet-beats-0_06-beats-revenue\" target=\"_blank\">Insulet beats by $0.06, beats on revenue</a> (Nov. 2)</li></ul><div class=\"tiny-share-widget\" data-id=\"3308175\" data-linked=\"Insulet Q3 beat and guidance raise propel shares, up 17%\" data-tweet=\"$PODD - Insulet Q3 beat and guidance raise propel shares, up 17% https://seekingalpha.com/news/3308175-insulet-q3-beat-and-guidance-raise-propel-shares-up-17?source=tweet\" data-url=\"https://seekingalpha.com/news/3308175-insulet-q3-beat-and-guidance-raise-propel-shares-up-17\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:05 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3308173\" data-ts=\"1509717373\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WING\" target=\"_blank\">WING</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3308173-wingstop-soars-after-posting-strong-growth\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Wingstop soars after posting strong growth</a></h4><ul> <li>Wingstop (NASDAQ:<a href='https://seekingalpha.com/symbol/WING' title='Wingstop, Inc.'>WING</a>) <font color='green'>jumps 16.2%</font> after topping Q3 sales estimates on the back of a 4% gain at comparable stores.</li> <li>The restaurant chain's bottom line benefited from a drop in average chicken wing costs to $1.88 per pound from a high of $2.16.</li> <li>Wingstop opened 32 restaurants in Q3 to top the 25 openings in Q2.</li> <li>Management says it's seeing good results from the test of delivery and digital ordering initiatives.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3307847-wingstop-beats-0_01-beats-revenue\" target=\"_blank\">Wingstop beats by $0.01, beats on revenue</a> (Nov. 2)</li></ul><div class=\"tiny-share-widget\" data-id=\"3308173\" data-linked=\"Wingstop soars after posting strong growth\" data-tweet=\"$WING - Wingstop soars after posting strong growth https://seekingalpha.com/news/3308173-wingstop-soars-after-posting-strong-growth?source=tweet\" data-url=\"https://seekingalpha.com/news/3308173-wingstop-soars-after-posting-strong-growth\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:56 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3308172\" data-ts=\"1509717307\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MSG\" target=\"_blank\">MSG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3308172-madison-square-garden-new-high-after-heavily-pared-losses\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Madison Square Garden at new high after heavily pared losses</a></h4><ul>   <li>Madison Square Garden (NASDAQ:<a href='https://seekingalpha.com/symbol/MSG' title='The Madison Square Garden Company'>MSG</a>) is <font color='green'>up 3%</font> in early going, and set a new 52-week high, after <a href=\"https://seekingalpha.com/news/3308074-madison-square-garden-beats-0_41-beats-revenue\" target=\"_blank\">Q1 earnings</a> where it posted a much smaller loss than expected as revenues jumped in its entertainment wing.</li>       <li>The inclusion of operating results for TAO Group drove most of the entertainment gains, along with higher overall event-related revenues at venues.</li>    <li>Overall revenues jumped 35%, and an operating loss of $15.7M was $17.2M better than the prior year.</li>    <li>Sports, meanwhile, saw higher revenues on higher league distributions, preseason ticket revenue and local media rights fees from MSG Networks.</li>    <li>Revenue breakout: MSG Entertainment, $164.1M (up 48%); MSG Sports, $80.9M (up 14%).</li>    <li><a href=\"http://www.themadisonsquaregardencompany.com\" target=\"_blank\">Conference call</a> to come at 10 a.m. ET.</li>    <li><a href=\"https://seekingalpha.com/pr/16990537-madison-square-garden-company-reports-fiscal-2018-first-quarter-results\" target=\"_blank\">Press Release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3308172\" data-linked=\"Madison Square Garden at new high after heavily pared losses\" data-tweet=\"$MSG - Madison Square Garden at new high after heavily pared losses https://seekingalpha.com/news/3308172-madison-square-garden-new-high-after-heavily-pared-losses?source=tweet\" data-url=\"https://seekingalpha.com/news/3308172-madison-square-garden-new-high-after-heavily-pared-losses\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:55 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3308156\" data-ts=\"1509714962\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3308156-premarket-gainers-of-9-05\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Gainers as of 9:05 am</a></h4><ul><li><a href='https://seekingalpha.com/symbol/ISIG' title='Insignia Systems, Inc.'>ISIG</a> <font color='green'>+20%</font>.</li><li><a href='https://seekingalpha.com/symbol/WING' title='Wingstop, Inc.'>WING</a> <font color='green'>+14%</font>&nbsp;on Q3 <a href=\"https://seekingalpha.com/news/3307847-wingstop-beats-0_01-beats-revenue\" target=\"_blank\">result</a>.</li><li><a href='https://seekingalpha.com/symbol/FND' title='Floor & Decor Holdings, Inc.'>FND</a> <font color='green'>+11%</font>&nbsp;on Q3 <a href=\"https://seekingalpha.com/news/3307723-floor-and-decor-holdings-beats-0_03-beats-revenue\" target=\"_blank\">result</a>.</li><li><a href='https://seekingalpha.com/symbol/ANET' title='Arista Networks, Inc.'>ANET</a> <font color='green'>+10%</font>&nbsp;on Q3 <a href=\"https://seekingalpha.com/news/3307667-arista-beats-0_43-beats-revenue\" target=\"_blank\">result</a>.</li><li><a href='https://seekingalpha.com/symbol/SMI' title='Semiconductor Manufacturing International Corporation'>SMI</a> <font color='green'>+9%</font>.</li><li><a href='https://seekingalpha.com/symbol/MELI' title='MercadoLibre, Inc.'>MELI</a> <font color='green'>+7%&nbsp;</font>on Q3 <a href=\"https://seekingalpha.com/news/3307764-mercadolibre-beats-0_01-beats-revenue\" target=\"_blank\">result</a>.</li><li><a href='https://seekingalpha.com/symbol/NTIP' title='Network-1 Technologies, Inc.'>NTIP</a> <font color='green'>+6%</font>&nbsp;on <a href=\"https://seekingalpha.com/pr/16990619-networkminus-1-announces-settlement-patent-litigation-juniper-networks-inc\" target=\"_blank\">settlement</a> of patent litigation against Juniper Networks.</li><li><a href='https://seekingalpha.com/symbol/MTBC' title='Medical Transcription Billing'>MTBC</a> <font color='green'>+6%</font>.</li><li><a href='https://seekingalpha.com/symbol/RCII' title='Rent-A-Center Inc.'>RCII</a> <font color='green'>+6%&nbsp;</font>after Vintage Capital makes <a href=\"https://seekingalpha.com/news/3308133-rent-center-jumps-vintage-capital-makes-offer\" target=\"_blank\">offer</a>.</li><li><a href='https://seekingalpha.com/symbol/KEM' title='KEMET Corp.'>KEM</a> <font color='green'>+6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3308156\" data-linked=\"Premarket Gainers as of 9:05 am\" data-tweet=\"$ISIG $WING $FND - Premarket Gainers as of 9:05 am https://seekingalpha.com/news/3308156-premarket-gainers-of-9-05?source=tweet\" data-url=\"https://seekingalpha.com/news/3308156-premarket-gainers-of-9-05\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:16 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3308154\" data-ts=\"1509714850\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MELI\" target=\"_blank\">MELI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3308154-mercadolibre-up-8_3-after-q3-beats\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">MercadoLibre up 8.3% after Q3 beats</a></h4><ul><li>        MercadoLibre (NASDAQ:<a href='https://seekingalpha.com/symbol/MELI' title='MercadoLibre, Inc.'>MELI</a>) shares are up 8.26% after Q3 results beat revenue and EPS estimates.</li><li>               Key metrics: Gross Merchandise Volume, $3.1M; items sold, 74.2M (+55.8%); items shipped, 41.7M (+80.4%); unique buyer growth, 31.1%; live listings on marketplace, 106M (+51%); gross profit margin, 47.4%; total operating expenses, $148.3M (+62%); cash from operations, $16.1M; cash and equivalents, $78.4M.&nbsp;</li><li>               <a href=\"https://seekingalpha.com/pr/16990139-mercadolibre-inc-reports-third-quarter-financial-results\" target=\"_blank\">Press release </a>&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3307764-mercadolibre-beats-0_01-beats-revenue\" target=\"_blank\">MercadoLibre beats by $0.01, beats on revenue</a> (Nov. 2)</li></ul><div class=\"tiny-share-widget\" data-id=\"3308154\" data-linked=\"MercadoLibre up 8.3% after Q3 beats\" data-tweet=\"$MELI - MercadoLibre up 8.3% after Q3 beats https://seekingalpha.com/news/3308154-mercadolibre-up-8_3-after-q3-beats?source=tweet\" data-url=\"https://seekingalpha.com/news/3308154-mercadolibre-up-8_3-after-q3-beats\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:14 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3308152\" data-ts=\"1509714733\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EDIT\" target=\"_blank\">EDIT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3308152-gene-editing-firms-up-premarket-on-bi-report\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Gene editing firms up premarket on BI report</a></h4><ul><li>Gene editing companies Editas Medicine (NASDAQ:<a href='https://seekingalpha.com/symbol/EDIT' title='Editas Medicine'>EDIT</a>) and Intellia Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/NTLA' title='Intellia Therapeutics'>NTLA</a>) are up&nbsp;<font color='green'>4%</font>&nbsp;and&nbsp;<font color='green'>2%</font>&nbsp;premarket, respectively, on the heels of a <a href=\"http://www.businessinsider.com/crispr-set-to-be-a-10-billion-market-by-2025-citi-2017-11\" target=\"_blank\">report</a> by Business Insider that the market for CRISPR/Cas9-related therapies will be $10B by 2025.</li><li>Nasdaq shows no premarket action for fellow CRISPR/Cas9 outfit CRISPR Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/CRSP' title='CRISPR Therapeutics'>CRSP</a>).</li></ul><div class=\"tiny-share-widget\" data-id=\"3308152\" data-linked=\"Gene editing firms up premarket on BI report\" data-tweet=\"$EDIT $EDIT $NTLA - Gene editing firms up premarket on BI report https://seekingalpha.com/news/3308152-gene-editing-firms-up-premarket-on-bi-report?source=tweet\" data-url=\"https://seekingalpha.com/news/3308152-gene-editing-firms-up-premarket-on-bi-report\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:12 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3308151\" data-ts=\"1509714639\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3308151-premarket-losers-of-9-05\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Losers as of 9:05 am</a></h4><ul>     <li><a href='https://seekingalpha.com/symbol/P' title='Pandora Media'>P</a>&nbsp;<font color='red'>-26%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3307672-pandora-media-beats-0_02-misses-revenue\" target=\"_blank\">Q3 earnings</a>.</li><li><a href='https://seekingalpha.com/symbol/CBL' title='CBL & Associates Properties, Inc.'>CBL</a>&nbsp;<font color='red'>-22%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3307766-cbl-and-associates-properties-misses-0_04\" target=\"_blank\">Q3 earnings</a>.</li><li><a href='https://seekingalpha.com/symbol/PACB' title='Pacific Biosciences of California'>PACB</a>&nbsp;<font color='red'>-16%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3308089-pacific-bio-q3-revenue-miss-sinks-shares-14-percent\" target=\"_blank\">Q3 earnings</a>.</li><li><a href='https://seekingalpha.com/symbol/DATA' title='Tableau Software'>DATA</a>&nbsp;<font color='red'>-13%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3307648-tableau-software-misses-0_01-misses-revenue\" target=\"_blank\">Q3 earnings</a>.</li><li><a href='https://seekingalpha.com/symbol/IMGN' title='ImmunoGen, Inc.'>IMGN</a>&nbsp;<font color='red'>-11%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3308031-immunogen-eps-0_61\" target=\"_blank\">Q3 earnings</a>.</li><li><a href='https://seekingalpha.com/symbol/STMP' title='Stamps.com Inc.'>STMP</a>&nbsp;<font color='red'>-7%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3307824-stamps-com-beats-0_73-beats-revenue\" target=\"_blank\">Q3 earnings</a>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3308151\" data-linked=\"Premarket Losers as of 9:05 am\" data-tweet=\"$P $CBL $PACB - Premarket Losers as of 9:05 am https://seekingalpha.com/news/3308151-premarket-losers-of-9-05?source=tweet\" data-url=\"https://seekingalpha.com/news/3308151-premarket-losers-of-9-05\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:10 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3308147\" data-ts=\"1509714244\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SRPT\" target=\"_blank\">SRPT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3308147-sarepta-on-go-early-stage-study-of-gene-therapy-galgt2-for-dmd-shares-up-1-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sarepta on go with early-stage study of gene therapy GALGT2 for DMD; shares up 1% premarket</a></h4><ul><li>Sarepta Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/SRPT' title='Sarepta Therapeutics, Inc.'>SRPT</a>) is up&nbsp;<font color='green'>1%</font>&nbsp;premarket on light volume on the heels of its <a href=\"https://seekingalpha.com/pr/16990657-sarepta-therapeutics-nationwide-children-s-hospital-announce-u-s-food-drug-administration-fda\" target=\"_blank\">announcement </a>that the FDA has signed off on its IND for gene therapy GALGT2 for the potential treatment of Duchenne muscular dystrophy &#40;DMD&#41;.</li><li>A Phase 1/2a clinical trial, expected to start by year-end, will be led by Nationwide Children's Hospital's Kevin Flanagan, M.D. Initial enrollment will be six patients.</li><li>In animal models, overexpression of GALGT2 produced normal muscle function even in the absence of dystrophin.</li><li>The company licensed GALGT2 from Nationwide in January.</li></ul><div class=\"tiny-share-widget\" data-id=\"3308147\" data-linked=\"Sarepta on go with early-stage study of gene therapy GALGT2 for DMD; shares up 1% premarket\" data-tweet=\"$SRPT - Sarepta on go with early-stage study of gene therapy GALGT2 for DMD; shares up 1% premarket https://seekingalpha.com/news/3308147-sarepta-on-go-early-stage-study-of-gene-therapy-galgt2-for-dmd-shares-up-1-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3308147-sarepta-on-go-early-stage-study-of-gene-therapy-galgt2-for-dmd-shares-up-1-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:04 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3308144\" data-ts=\"1509714117\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SBUX\" target=\"_blank\">SBUX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3308144-starbucks-execs-talk-up-u-s-performance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Starbucks execs talk up U.S. performance</a></h4><ul> <li>Starbucks (NASDAQ:<a href='https://seekingalpha.com/symbol/SBUX' title='Starbucks Corporation'>SBUX</a>) execs defended the company's performance in the U.S. during yesterday's conference call.</li> <li>They noted that the chain has easily outperformed the U.S. retail restaurant industry averages on a traffic and comparable sales basis and teased that the \"holiday plan\" in place gives the restaurant operator an extra dose of confidence.</li> <li>On profitability, SBUX management noted that operational savings are due to be seen in the U.S. business and the company is set to raise EPS the old-fashioned way - lowering share count via buybacks.</li> <li>On Wall Street, Bernstein analyst Sara Senatore notes that underlying Starbucks traffic trends were the best in six quarters and throughput (line speed) is improving. Wells Fargo's Bonnie Herzog says she is \"highly encouraged\" by Starbucks' plan to lean into stronger businesses such as China.</li> <li>Sources: <a href=\"https://seekingalpha.com/article/4119966-starbucks-sbux-q4-2017-results-earnings-call-transcript?part=single\" target=\"_blank\">Starbucks earnings call transcript</a>, Bloomberg</li> <li>Shares of Starbucks are&nbsp;<font color='red'>down 0.75%</font>&nbsp;premarket to $54.46 after being down as much as 6% in the AH session yesterday.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3307721-starbucks-lower-earnings\" target=\"_blank\">Starbucks lower after earnings</a> (Nov. 2)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3308144\" data-linked=\"Starbucks execs talk up U.S. performance\" data-tweet=\"$SBUX - Starbucks execs talk up U.S. performance https://seekingalpha.com/news/3308144-starbucks-execs-talk-up-u-s-performance?source=tweet\" data-url=\"https://seekingalpha.com/news/3308144-starbucks-execs-talk-up-u-s-performance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:01 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3308136\" data-ts=\"1509713562\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HMSY\" target=\"_blank\">HMSY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3308136-on-hms-holdings-q3\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on HMS Holdings&#39; Q3</a></h4><ul><li>HMS Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/HMSY' title='HMS Holdings Corp'>HMSY</a>) reports&nbsp;Commercial revenue rose 16.8% to $67.6M in <a href=\"https://seekingalpha.com/pr/16990454-hms-holdings-corp-reports-third-quarter-2017-results\" target=\"_blank\">Q3</a>.</li><li>Payment integrity revenue (excl. Medicare RAC) up 16% to $31.2M.</li><li>Coordination of benefits&nbsp;revenue increased 4.5% to $90.1M.</li><li>Operating margin rate -10 bps to 10.2%.</li><li>SG&amp;A expense rate improved 110 bps to 17.7%.</li><li>Adjusted EBITDA grew 32% to $34.12M.</li><li>The company expects FY2017 revenue to be in the range of $508M to $513M and Q4 revenue to be between $135M to $140M.</li></ul><div class=\"tiny-share-widget\" data-id=\"3308136\" data-linked=\"More on HMS Holdings&#39; Q3\" data-tweet=\"$HMSY - More on HMS Holdings&#39; Q3 https://seekingalpha.com/news/3308136-on-hms-holdings-q3?source=tweet\" data-url=\"https://seekingalpha.com/news/3308136-on-hms-holdings-q3\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:52 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3308135\" data-ts=\"1509713398\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CTRL\" target=\"_blank\">CTRL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3308135-control4-up-3-after-q3-beats-in-line-q4-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Control4 up 3% after Q3 beats, in-line Q4 guidance</a></h4><ul><li>        Control4 (NASDAQ:<a href='https://seekingalpha.com/symbol/CTRL' title='Control4 Corporation'>CTRL</a>) shares are&nbsp;<font color='green'>up 3.25%</font>&nbsp;premarket after yesterday&rsquo;s Q3 report beat EPS and revenue estimates with in-line guidance. Q4 guidance puts revenue from $66.3M to $68.3M (consensus: $66.93M) with EPS from $0.33 to $0.37 (consensus: $0.34). &nbsp;</li><li>        Full-year 2017 guidance has revenue from $242.5M to $244.5M (consensus: $242.22M) and $1.13 to $1.16 (consensus: $1.04).</li><li>                  Revenue: North America Core, $48.7M; International Core, $14M; Other, $2M.    </li><li>               <a href=\"https://seekingalpha.com/pr/16989981-control4-reports-financial-results-third-quarter-2017\" target=\"_blank\">Press release</a>&nbsp; &nbsp;&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3307703-control4-beats-0_09-beats-revenue\" target=\"_blank\">Control4 beats by $0.09, beats on revenue</a> (Nov. 2)</li></ul><div class=\"tiny-share-widget\" data-id=\"3308135\" data-linked=\"Control4 up 3% after Q3 beats, in-line Q4 guidance\" data-tweet=\"$CTRL - Control4 up 3% after Q3 beats, in-line Q4 guidance https://seekingalpha.com/news/3308135-control4-up-3-after-q3-beats-in-line-q4-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3308135-control4-up-3-after-q3-beats-in-line-q4-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:49 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3308133\" data-ts=\"1509713254\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RCII\" target=\"_blank\">RCII</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3308133-rent-center-jumps-after-vintage-capital-makes-offer\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Rent-A-Center jumps after Vintage Capital makes offer</a></h4><ul> <li>Vintage Capital makes an offer to buy Rent-A-Center (NASDAQ:<a href='https://seekingalpha.com/symbol/RCII' title='Rent-A-Center Inc.'>RCII</a>) for $13 per share.</li> <li>The disclosure was made in a 13D filing that also indicated that Vintage has a 5.6% stake already in its back pocket.</li> <li><a href=\"http://archive.fast-edgar.com//20171103/ALA2PQ2CZZ22VZZK22JQ2ZZHFTGK2B22Z292/\" target=\"_blank\">SEC 13D</a></li> <li>Shares of Rent-A-Center are <font color='green'>up 6.35%</font> in premarket trading to $10.55.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3308133\" data-linked=\"Rent-A-Center jumps after Vintage Capital makes offer\" data-tweet=\"$RCII - Rent-A-Center jumps after Vintage Capital makes offer https://seekingalpha.com/news/3308133-rent-center-jumps-after-vintage-capital-makes-offer?source=tweet\" data-url=\"https://seekingalpha.com/news/3308133-rent-center-jumps-after-vintage-capital-makes-offer\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:47 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>25&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3308132\" data-ts=\"1509712883\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/REV\" target=\"_blank\">REV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3308132-on-revlons-q3\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on Revlon&#39;s Q3</a></h4><ul>     <li>Revlon (NYSE:<a href='https://seekingalpha.com/symbol/REV' title='Revlon, Inc.'>REV</a>)&nbsp;reports pro forma net sales down 11.6% XFX in <a href=\"https://seekingalpha.com/pr/16990539-revlon-reports-third-quarter-2017-results\" target=\"_blank\">Q3</a>, primarily due to sales declines in the&nbsp;North America&nbsp;mass retail channel.</li>     <li>Consumer segment net sales decreased 10.5% to $306.7M, primarily driven by net sales declines in the mass retail channel in&nbsp;North America&nbsp;due to continued softness in consumption, inventory de-stocking by certain retail customers and higher sales returns and incentives.</li>     <li>Professional segment net sales declined 9.9% to $107M, driven by continued lower net sales of CND nail products and American Crew men&rsquo;s grooming products.</li>     <li>Elizabeth Arden net sales expanded 83.5% to $248.1M.</li>     <li>Gross margin rate squeezed 400 bps to 56.5%.</li>     <li>Pro forma adjusted EBITDA fell 48.9% to $53.6M.</li>      </ul><div class=\"tiny-share-widget\" data-id=\"3308132\" data-linked=\"More on Revlon&#39;s Q3\" data-tweet=\"$REV - More on Revlon&#39;s Q3 https://seekingalpha.com/news/3308132-on-revlons-q3?source=tweet\" data-url=\"https://seekingalpha.com/news/3308132-on-revlons-q3\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:41 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3308131\" data-ts=\"1509712851\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BVX\" target=\"_blank\">BVX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3308131-bovie-medical-q3-miss-and-lower-guidance-pressures-shares-down-12-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bovie Medical Q3 miss and lower guidance pressures shares, down 12% premarket</a></h4><ul><li>Thinly traded micro cap Bovie Medical (NYSEMKT:<a href='https://seekingalpha.com/symbol/BVX' title='Bovie Medical Corporation'>BVX</a>) slips&nbsp;<font color='red'>12%</font>&nbsp;premarket on light volume on the heels of its <a href=\"https://seekingalpha.com/pr/16989954-bovie-medical-corporation-reports-third-quarter-2017-financial-results-updates-fiscal-year\" target=\"_blank\">Q3 results</a> released yesterday after the close that missed consensus.</li><li>Revenues: $9.3M (-7.1%); Net Loss: ($1.2M) (-29.0%).</li><li><strong>2017 Guidance</strong>: Total revenues: $37.9M - 38.4M (4 -5% growth) from 5 - 11% growth; non-GAAP EBITDA loss: ($2.8M - 3.0M) from ($1.2M - 1.4M).</li><li>Previously: <a href=\"https://seekingalpha.com/news/3307699-bovie-medical-misses-0_03-misses-revenue\" target=\"_blank\">Bovie Medical misses by $0.03, misses on revenue</a> (Nov. 2)</li></ul><div class=\"tiny-share-widget\" data-id=\"3308131\" data-linked=\"Bovie Medical Q3 miss and lower guidance pressures shares, down 12% premarket\" data-tweet=\"$BVX - Bovie Medical Q3 miss and lower guidance pressures shares, down 12% premarket https://seekingalpha.com/news/3308131-bovie-medical-q3-miss-and-lower-guidance-pressures-shares-down-12-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3308131-bovie-medical-q3-miss-and-lower-guidance-pressures-shares-down-12-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:40 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3308130\" data-ts=\"1509712829\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3308130-ue-rate-hits-lowest-since-2000-alongside-big-slide-in-labor-force-participation\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">UE rate hits lowest since 2000 alongside big slide in labor force participation</a></h4><ul><li>Alongside 261K jobs added in October, September's 33K job loss was revised to a gain of 18K, and August's 169K jobs added was revised up to 208K. Adding it all up, we'll call the report inline on that basis.</li><li>The unemployment rate did fall to 4.1%, but that came thanks a big decline in labor force participation to 62.7% from 63.1%. The U-6 unemployment rate fell to 7.9% from 8.3%. A year ago, it was at 9.5%.</li><li>The average workweek was flat in October at 34.4 hours. Average hourly earnings of $26.53 dipped by a penny, and rose 2.4% on a Y/Y basis.</li><li>The Street's verdict at the moment says \"miss,\" with the 10-year Treasury yield down two basis points to 2.33%. <a href='https://seekingalpha.com/symbol/TLT' title='iShares 20+ Year Treasury Bond ETF'>TLT</a>&nbsp;<font color='green'>+0.2%</font>, <a href='https://seekingalpha.com/symbol/TBT' title='ProShares UltraShort 20+ Year Treasury ETF'>TBT</a>&nbsp;<font color='red'>-0.4%</font></li><li>The dollar (NYSEARCA:<a href='https://seekingalpha.com/symbol/UUP' title='PowerShares DB USD Bull ETF'>UUP</a>) has moved modestly lower, and gold (NYSEARCA:<a href='https://seekingalpha.com/symbol/GLD' title='SPDR Gold Trust ETF'>GLD</a>) has added about $5 per ounce.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3308122-261k-jobs-added-october-ue-rate-drops-4_1-percent\" target=\"_blank\">261K jobs added in October, UE rate drops to 4.1%</a> (Nov. 3)</li></ul><div class=\"tiny-share-widget\" data-id=\"3308130\" data-linked=\"UE rate hits lowest since 2000 alongside big slide in labor force participation\" data-tweet=\"$TLT $TBT $UUP - UE rate hits lowest since 2000 alongside big slide in labor force participation https://seekingalpha.com/news/3308130-ue-rate-hits-lowest-since-2000-alongside-big-slide-in-labor-force-participation?source=tweet\" data-url=\"https://seekingalpha.com/news/3308130-ue-rate-hits-lowest-since-2000-alongside-big-slide-in-labor-force-participation\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:40 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>23&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3308121\" data-ts=\"1509712198\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OTEX\" target=\"_blank\">OTEX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3308121-open-text-up-after-q1-results-14-cloud-growth\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Open Text up after Q1 results with 14% cloud growth</a></h4><ul><li>        Open Text (NASDAQ:<a href='https://seekingalpha.com/symbol/OTEX' title='Open Text Corporation'>OTEX</a>) shares are&nbsp;<font color='green'>up 1.11%</font>&nbsp;premarket after yesterday&rsquo;s Q1 results beat revenue and met on EPS.</li><li>               Revenue: Cloud services and subscriptions, $193.9M (+14.2%); customer support, $295.4M (+40.5%); total annual recurring revenues, $489.3M (+28.8%); license, $78.2M (+17.6%); professional service and other, $73.2M (+43.2%).&nbsp;</li><li>               Key metrics: Non-GAAP gross margin, 72.2% (+70 bps); operating margin, 31.4% (+60 bps); cash and equivalents, $376M.</li><li>               <a href=\"https://seekingalpha.com/pr/16989903-opentext-reports-first-quarter-fiscal-year-2018-financial-results\" target=\"_blank\">Press release</a>&nbsp;&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3307658-open-text-eps-line-beats-revenue\" target=\"_blank\">Open Text EPS in-line, beats on revenue</a> (Nov. 2)</li></ul><div class=\"tiny-share-widget\" data-id=\"3308121\" data-linked=\"Open Text up after Q1 results with 14% cloud growth\" data-tweet=\"$OTEX - Open Text up after Q1 results with 14% cloud growth https://seekingalpha.com/news/3308121-open-text-up-after-q1-results-14-cloud-growth?source=tweet\" data-url=\"https://seekingalpha.com/news/3308121-open-text-up-after-q1-results-14-cloud-growth\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:29 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3308120\" data-ts=\"1509712100\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/APO\" target=\"_blank\">APO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3308120-pe-firms-said-to-be-stalking-qdoba\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">PE firms said to be stalking Qdoba</a></h4><ul> <li>Private equity bidders including Apollo Global Management (NYSE:<a href='https://seekingalpha.com/symbol/APO' title='Apollo Global Management, LLC'>APO</a>) are in <a href=\"http://nypost.com/2017/11/02/leon-blacks-apollo-global-eyeing-qdoba/\" target=\"_blank\">advanced talks</a> to acquire Qdoba from Jack In The Box (NASDAQ:<a href='https://seekingalpha.com/symbol/JACK' title='Jack In The Box Inc.'>JACK</a>), sources tell New York Post.</li> <li>The restaurant company is said to be only a few weeks away from taking final bids.</li> <li>Qdoba, which operates 720 stores, is expected to be sold for $250M to $500M.</li> <li>JACK <font color='green'>+0.78%</font> premarket to $102.00.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3308120\" data-linked=\"PE firms said to be stalking Qdoba\" data-tweet=\"$APO $APO $JACK - PE firms said to be stalking Qdoba https://seekingalpha.com/news/3308120-pe-firms-said-to-be-stalking-qdoba?source=tweet\" data-url=\"https://seekingalpha.com/news/3308120-pe-firms-said-to-be-stalking-qdoba\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:28 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3308112\" data-ts=\"1509711110\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RMAX\" target=\"_blank\">RMAX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3308112-re-max-postpones-earnings-amid-investigation-shares-down-8_5\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Re/Max postpones earnings amid investigation; shares down 8.5%</a></h4><ul><li>A special committee of the board is looking into charges relating to certain of its senior management. In particular, there's an allegation of a personal loan of $2.375M between the two co-CEOs.</li><li>The co-CEOs have confirmed the loan and that is was made for the purchase of residence. They say no company funds were involved.</li><li>Source: <a href=\"https://seekingalpha.com/pr/16990191-re-max-holdings-postpones-third-quarter-earnings-release-conference-call\" target=\"_blank\">Press Release</a></li><li><a href='https://seekingalpha.com/symbol/RMAX' title='RE/MAX Holdings, Inc.'>RMAX</a>&nbsp;<font color='red'>-8.55%</font>&nbsp;premarket</li></ul><div class=\"tiny-share-widget\" data-id=\"3308112\" data-linked=\"Re/Max postpones earnings amid investigation; shares down 8.5%\" data-tweet=\"$RMAX - Re/Max postpones earnings amid investigation; shares down 8.5% https://seekingalpha.com/news/3308112-re-max-postpones-earnings-amid-investigation-shares-down-8_5?source=tweet\" data-url=\"https://seekingalpha.com/news/3308112-re-max-postpones-earnings-amid-investigation-shares-down-8_5\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:11 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3308109\" data-ts=\"1509710976\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AXL\" target=\"_blank\">AXL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3308109-american-axle-and-amp-manufacturing-beats-0_20-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">American Axle &amp;amp; Manufacturing beats by $0.20, beats on revenue</a></h4><ul><li>American Axle &amp; Manufacturing (NYSE:<a href='https://seekingalpha.com/symbol/AXL' title='American Axle & Manufacturing Holdings, Inc.'>AXL</a>): Q3 EPS of $0.86 <font color='green'>beats by $0.20</font>.</li><li>Revenue of $1.72B (+70.3% Y/Y) <font color='green'>beats by $90M</font>.</li><li>Shares <font color='green'>+3%</font> PM.</li><li><a href='https://seekingalpha.com/pr/16990576-aam-reports-third-quarter-2017-financial-results'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3308109\" data-linked=\"American Axle &amp;amp; Manufacturing beats by $0.20, beats on revenue\" data-tweet=\"$AXL - American Axle &amp; Manufacturing beats by $0.20, beats on revenue https://seekingalpha.com/news/3308109-american-axle-and-amp-manufacturing-beats-0_20-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3308109-american-axle-and-amp-manufacturing-beats-0_20-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:09 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3308105\" data-ts=\"1509710843\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ACIA\" target=\"_blank\">ACIA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3308105-acacia-communications-down-2-after-q3-beats-downside-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Acacia Communications down 2% after Q3 beats, downside guidance</a></h4><ul><li>        Acacia Communications (NASDAQ:<a href='https://seekingalpha.com/symbol/ACIA' title='Acacia Communications'>ACIA</a>) shares are&nbsp;<font color='red'>down 2.17%&nbsp;</font>premarket after yesterday&rsquo;s Q3 report beat EPS and revenue estimates but included downside guidance. The Q4 guidance puts revenue from $83M to $93M (consensus: $113.12M) with EPS from $0.19 to $0.36 (consensus: $0.47). &nbsp;</li><li>        Key metrics: Non-GAAP gross margin, 43.7%; income from operations, $14.6M; adjusted EBITDA, $17.8M; cash and equivalents, $115.76M; total operating expenses, $37.2M.</li><li>               Analyst upgrade: B. Riley <a href=\"http://www.briefing.com/DisplayArticle/ArticlePopup.aspx?ArticleId=IN20171103072005ACIA\" target=\"_blank\">upgrades</a> Acacia from Neutral to Buy and ups its price target by $5 to $49.&nbsp;</li><li>               The firm cites improving China demand and new product ramp up.&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3307696-acacia-communications-beats-0_11-beats-revenue\" target=\"_blank\">Acacia Communications beats by $0.11, beats on revenue</a> (Nov. 2)</li></ul><div class=\"tiny-share-widget\" data-id=\"3308105\" data-linked=\"Acacia Communications down 2% after Q3 beats, downside guidance\" data-tweet=\"$ACIA - Acacia Communications down 2% after Q3 beats, downside guidance https://seekingalpha.com/news/3308105-acacia-communications-down-2-after-q3-beats-downside-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3308105-acacia-communications-down-2-after-q3-beats-downside-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:07 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li>","count":75,"message":null,"success":true,"today":{"start":1577077200,"end":1577163599,"str":"Monday, December 23, 2019"},"yesterday":{"start":1576990800,"end":1577077199}}